This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)
C3_ENDOCRINE_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersNone 0 out of 7 registries used, show all original rules. |
0 |
4. Check minimum number of eventsNone |
0 |
5. Include endpoints |
3333 |
6. Filter based on genotype QC (FinnGen only) |
3333 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)
- Any event in hilmo or specialist outpatient
Similar with less cases:
- Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of endocrine gland
- Malignant neoplasm of thyroid gland
- Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)
- Papillary adenocarcinoma of thyroid gland
Case counts by codes
↥FinnGen case counts by registry codes:
No data for upset plot.
No data for upset table.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 3333 | 2390 | 943 |
| Unadjusted period prevalence (%) | 0.70 | 0.81 | 0.42 |
| Median age at first event (years) | 51.97 | 49.34 | 58.62 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 2567
- Matched controls
- 25680
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
130
Kela drug reimbursment
Malignant tumour
+∞
323.0
333
*
BAA60
NOMESCO Finland
Total thyroidectomy
147.5
323.0
1351
192
ZX114
NOMESCO Finland
Intramuscular
51.6
323.0
420
97
E89.01
ICD-10 Finland
Postsurgical hypothyroidism
80.1
323.0
706
121
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
323.0
1816
*
XX7CT
NOMESCO Finland
Radioiodine therapy of thydoid tissue
183.1
323.0
676
50
C73.90
ICD-10 Finland
Malignant tumor of the thyroid gland (thyroid gland) without histology
+∞
323.0
342
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
51.1
323.0
1223
449
104
Kela drug reimbursment
Thyroid insufficiency
58.9
323.0
1813
1005
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
5.3
323.0
1472
5183
JN5PN
NOMESCO Finland
Isotope imaging of secondary neoplasms of thyroid origin
+∞
323.0
620
*
D44.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Thyroid gland
118.6
323.0
656
74
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
323.0
1877
*
BAA40
NOMESCO Finland
Unilateral lobectomy of thyroid gland
29.8
323.0
560
238
H03AA01
ATC
levothyroxine sodium; systemic
50.6
323.0
2330
4161
JN5AQ
NOMESCO Finland
SPECT of thyroid metastasis with low-dose CT
3329.6
323.0
306
*
C73
ICD-10 Finland
Malignant neoplasm of thyroid gland
3990.3
323.0
357
*
C73.99
ICD-10 Finland
Malignant tumor of the thyroid gland (thyroid gland), other or unspecified histology
+∞
313.0
294
*
4CJ01
NOMESCO Finland
NA
+∞
308.7
290
*
C73.92
ICD-10 Finland
Follicular carcinoma of the thyroid gland
+∞
298.9
281
*
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
36.4
265.4
345
109
1930A
ICD-9 Finland
Malignant neoplasm of thyroid gland[CARCINOMA PAPILLARE THYREOIDEAE]
+∞
221.1
209
*
BA1NN
NOMESCO Finland
I-131 dose capsel measurement
+∞
213.5
202
*
8330/3-C73.9
ICD-O-3
Follicular carcinoma, NOS, of thyroid gland
+∞
206.0
195
*
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
1966.4
201.6
193
*
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
21.0
190.4
289
154
E04.2
ICD-10 Finland
Nontoxic multinodular goitre
9.3
173.1
383
475
115
Kela drug reimbursment
Breast cancer
+∞
169.7
161
*
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
75.3
166.4
189
27
T71
ICPC
Malignant neoplasm thyroid
+∞
165.4
157
*
H02AB02
ATC
dexamethasone; systemic
24.3
165.3
239
108
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
99.8
153.2
168
18
WX408
NOMESCO Finland
General anesthesy, balanced
3.4
152.0
963
3834
E89.2
ICD-10 Finland
Postprocedural hypoparathyroidism
82.8
151.5
170
22
A11CC03
ATC
alfacalcidol; systemic
16.8
151.1
248
162
2506
FHL
Thyroidectomy
200.3
146.4
151
8
PJA12
NOMESCO Finland
Sentinel node biopsy
363.8
139.2
139
*
106
Kela drug reimbursment
Hypoparathyroidism
100.2
137.7
151
16
19399
ICD-8 Finland
Malignant neoplasm of thyroid gland
+∞
136.7
130
*
A04AA02
ATC
granisetron; systemic, transdermal
182.1
132.9
138
8
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.1
131.1
993
4390
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.4
127.3
757
2800
ZXE10
NOMESCO Finland
More than one and less than three hours
2.8
125.1
1172
5897
WX402
NOMESCO Finland
General anaesthesia
3.8
121.5
608
1948
Z51.88
ICD-10 Finland
Other specified medical care
15.6
120.6
203
140
8341/3-C73.9
ICD-O-3
Papillary microcarcinoma of thyroid gland
+∞
119.7
114
*
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
+∞
119.7
114
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
302.5
114.0
115
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
112.3
107
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
108.1
103
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
517.6
101.3
100
*
E04.1
ICD-10 Finland
Nontoxic single thyroid nodule
11.8
99.1
189
172
C739
ICD-10 Finland
NA
+∞
98.6
94
*
BA1AE
NOMESCO Finland
Thyroiid ultrasound examination
12.7
96.7
178
150
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
95.4
91
*
WF002
NOMESCO Finland
Radical radiotherapy
91.2
94.8
105
12
JN4BD
NOMESCO Finland
Extensive body CT
6.2
94.2
272
484
E89.09
ICD-10 Finland
Postprocedural hypothyroidism, other or several procedures
47.6
93.3
114
25
8340/3-C73.9
ICD-O-3
Papillary carcinoma, follicular variant of thyroid gland
+∞
93.3
89
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
145.4
92.7
98
7
E04.9
ICD-10 Finland
Nontoxic goitre, unspecified
8.6
88.4
200
249
D34
ICD-10 Finland
Benign neoplasm of thyroid gland
26.0
88.1
124
50
XX3DW
NOMESCO Finland
Time consuming IT work
6.0
87.4
257
467
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
85.9
82
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
436.7
85.6
85
*
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
44.1
85.5
106
25
ZXE20
NOMESCO Finland
More than three and less than five hours
3.5
85.3
459
1516
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
22.6
81.2
119
55
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
813.1
80.9
79
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
79.6
76
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
77.5
74
*
A03FA01
ATC
metoclopramide; systemic, rectal
3.1
75.6
492
1850
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
57.5
75.4
89
16
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
75.4
72
*
HAC20
NOMESCO Finland
Total mastectomy
137.5
75.4
80
6
WB223
NOMESCO Finland
Demanding adjuvant hormone therapy of malignancy
+∞
73.3
70
*
L02BA01
ATC
tamoxifen; oral
113.3
71.3
77
7
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
6.2
70.8
200
343
L03AA13
ATC
pegfilgrastim; parenteral
707.0
70.4
69
*
A11CC02
ATC
dihydrotachysterol; oral
46.7
70.3
86
19
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
+∞
70.1
67
*
JN4AD
NOMESCO Finland
Body CT examination
7.1
68.7
176
264
D44.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Adrenal gland
18.6
68.5
107
60
TPH07
NOMESCO Finland
Cathetrisation of artery
3.8
68.0
320
936
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
174.5
65.3
68
*
ZXD10
NOMESCO Finland
Scheduled procedure
2.1
64.1
1087
6672
E83.51
ICD-10 Finland
Hypocalcemia
22.9
63.9
93
42
WZC30
NOMESCO Finland
Teaching
3.3
63.9
362
1223
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
169.2
63.3
66
*
HA1AA
NOMESCO Finland
X-ray mammography
5.9
62.7
185
335
A12AA04
ATC
calcium carbonate; oral
12.5
62.7
115
96
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
8.2
61.9
143
183
EP2AT
NOMESCO Finland
Neck soft tissue cytology with ultrasound guidance
112.8
61.1
66
6
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
59.6
57
*
A04AA01
ATC
ondansetron; systemic, rectal
7.1
58.4
149
222
GD1AD
NOMESCO Finland
Thorax CT examination
6.0
58.0
167
293
C73.94
ICD-10 Finland
Medullary thyroid carcinoma (thyroid)
+∞
56.4
54
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
56.4
54
*
UDQ12
NOMESCO Finland
Flexible laryngoscopy
4.0
56.2
241
647
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
30.8
56.1
75
25
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
5.7
56.0
170
318
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
549.3
54.7
54
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
282.1
54.4
55
*
JN5SN
NOMESCO Finland
NA
+∞
54.4
52
*
HAB40
NOMESCO Finland
Wedge excision of mammary gland
22.6
54.2
79
36
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
190.7
54.2
56
*
116
Kela drug reimbursment
Prostate cancer
+∞
53.3
51
*
C74.0
ICD-10 Finland
Malignant neoplasm: Cortex of adrenal gland
+∞
53.3
51
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
260.3
50.2
51
*
XX9AQ
NOMESCO Finland
Supplementary SPECT-CT or additional scan
+∞
49.1
47
*
PJD91
NOMESCO Finland
Excision of lymph nodes in neck, 1 to 2 areas in total
173.3
49.0
51
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
48.9
1047
6818
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
48.1
46
*
C50.99
ICD-10 Finland
Breast, unspecified
476.3
47.5
47
*
2505
FHL
Bilateral resection (also used if total removal has been performed on the other side)
16.2
47.1
77
49
WF004
NOMESCO Finland
Palliative radiotherapy
244.4
47.1
48
*
A04AA55
ATC
palonosetron, combinations; systemic
465.9
46.4
46
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
10.1
46.4
94
96
A12AA06
ATC
calcium lactate gluconate; oral
75.9
46.1
52
7
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
46.0
44
*
Z51.5
ICD-10 Finland
Palliative care
8.1
45.6
105
134
BCA31
NOMESCO Finland
Endoscopic unilateral adrenalectomy
30.1
44.1
59
20
C74.9
ICD-10 Finland
Malignant neoplasm: Adrenal gland, unspecified
+∞
43.9
42
*
WW200
NOMESCO Finland
Immunization
5.7
43.3
129
236
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
42.8
41
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
4.4
42.7
164
395
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
4.2
42.2
167
414
L02BG04
ATC
letrozole; oral
8.3
42.0
95
118
C74.1
ICD-10 Finland
Malignant neoplasm: Medulla of adrenal gland
+∞
41.8
40
*
ZXE30
NOMESCO Finland
More than five and less than seven hours
4.5
40.7
151
352
L03AA02
ATC
filgrastim; parenteral
45.3
40.1
49
11
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
39.7
38
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
58.5
39.4
46
8
WX704
NOMESCO Finland
Intubation
3.1
39.2
227
767
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
38.6
37
*
C73.93
ICD-10 Finland
Anaplastic thyroid carcinoma (thyroid)
+∞
38.6
37
*
N02BE01
ATC
paracetamol; systemic, rectal
2.0
38.5
2175
18849
JN6AD
NOMESCO Finland
CT of torso and neck
25.0
38.5
54
22
E27.5
ICD-10 Finland
Adrenomedullary hyperfunction
382.9
38.1
38
*
8700/3-C74.9
ICD-O-3
Pheochromocytoma, NOS, of adrenal gland, NOS
+∞
37.6
36
*
L01BC06
ATC
capecitabine; oral
+∞
37.6
36
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
192.7
36.9
38
*
C50
ICD-10 Finland
Malignant neoplasm of breast
+∞
36.5
35
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
36.5
35
*
N02AA05
ATC
oxycodone; systemic
2.6
36.5
293
1216
BAA99
NOMESCO Finland
Other operation on thyroid gland
187.6
35.8
37
*
ZXA10
NOMESCO Finland
Bilateral
2.0
35.8
523
2885
NK6AN
NOMESCO Finland
Total body bone isotope imaging
31.9
35.7
47
15
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
35.5
34
*
ZXA05
NOMESCO Finland
Left side
1.9
35.2
638
3813
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
9.7
35.0
72
76
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
34.4
33
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
34.4
33
*
8290/3-C73.9
ICD-O-3
Oxyphilic adenocarcinoma of thyroid gland
+∞
34.4
33
*
B01AB05
ATC
enoxaparin; parenteral
1.8
33.9
695
4323
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
33.4
32
*
BCA30
NOMESCO Finland
Unilateral adrenalectomy
56.5
33.3
39
7
XX6XT
NOMESCO Finland
Other intravascular therapy with radiological guidance
21.2
32.6
48
23
T86
ICPC
Hypothyroidism/myxoedema
3.5
32.5
160
480
ZXE00
NOMESCO Finland
One hour or less
1.7
32.4
991
6958
Z85.8
ICD-10 Finland
Personal history of malignant neoplasms of other organs and systems
+∞
32.4
31
*
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
+∞
32.4
31
*
PJD51
NOMESCO Finland
Block dissection of cervical lymph nodes
+∞
32.4
31
*
JN4CD
NOMESCO Finland
Very extensive body CT
6.6
32.0
84
131
ZX080
NOMESCO Finland
Image guided radiotherapy
320.8
31.9
32
*
GD6AD
NOMESCO Finland
CT of chest and neck
48.1
31.6
38
8
C75.0
ICD-10 Finland
Malignant neoplasm: Parathyroid gland
+∞
31.3
30
*
198
Kela drug reimbursment
Sorafenib
+∞
31.3
30
*
E03.89
ICD-10 Finland
Other specified hypothyroidism
3.7
30.6
140
395
BA1AQ
NOMESCO Finland
Thyroid SPECT with low dose CT
305.8
29.9
30
*
A04AD12
ATC
aprepitant; systemic
156.8
29.7
31
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
29.2
28
*
E21.09
ICD-10 Finland
Other primary hyperparathyroidism
5.3
29.0
90
174
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
8.2
28.8
65
81
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
+∞
28.2
27
*
8510/3-C73.9
ICD-O-3
Medullary carcinoma, NOS, of thyroid gland
+∞
28.2
27
*
ZSB00
NOMESCO Finland
Procedure related to previous procedure classified in chapter B
64.7
28.0
32
5
BBA30
NOMESCO Finland
Excision of lesion of parathyroid gland
6.4
27.9
75
121
O99.2
ICD-10 Finland
Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium
6.3
27.3
74
121
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
12.5
27.3
49
40
ZXA00
NOMESCO Finland
Right side
1.7
27.2
654
4232
8345/3-C73.9
ICD-O-3
Medullary thyroid carcinoma of thyroid gland
+∞
27.1
26
*
E04.0
ICD-10 Finland
Nontoxic diffuse goitre
8.6
27.0
59
70
WX302
NOMESCO Finland
Thoracal epidural anesthesy
4.3
26.9
102
244
Y77
ICPC
Malignant neoplasm prostate
76.0
26.8
30
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
41.7
26.8
33
8
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
273.8
26.8
27
*
PJD99
NOMESCO Finland
Excision of other lymph nodes
273.8
26.8
27
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
273.8
26.8
27
*
L03AA14
ATC
lipegfilgrastim; parenteral
273.8
26.8
27
*
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
25.0
26.6
37
15
XX1MN
NOMESCO Finland
Isotope examination with measurement
+∞
26.1
25
*
Z31.5
ICD-10 Finland
Genetic counselling
3.3
25.7
136
431
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
22.1
25.6
37
17
TPH04
NOMESCO Finland
Cathetrisation of vein
1.8
25.6
468
2767
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
+∞
25.0
24
*
E8901, C7391
ICD-10 Finland
NA
+∞
25.0
24
*
H02AB09
ATC
hydrocortisone; systemic
4.5
24.9
89
201
A79
ICPC
Malignancy NOS
70.6
24.8
28
*
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
10.6
24.8
48
46
XW000
NOMESCO Finland
Bone marrow biopsy
4.2
24.5
95
232
DQE10
NOMESCO Finland
Injection of foreign material into vocal cord
17.5
24.4
38
22
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
15.8
24.1
39
25
8370/3-C74.0
ICD-O-3
Adrenal cortical carcinoma of cortex of adrenal gland
+∞
24.0
23
*
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
24.0
23
*
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
4.3
23.7
89
211
PJA10
NOMESCO Finland
Exploration of lymph nodes
12.6
23.1
41
33
L02BG03
ATC
anastrozole; oral
54.5
23.1
27
5
HAB50
NOMESCO Finland
Partial excision of mammary gland with reconstructive operation
54.5
23.1
27
5
323
Kela drug reimbursment
Sorafenib
+∞
22.9
22
*
8700/3-C74.1
ICD-O-3
Pheochromocytoma, NOS, of medulla of adrenal gland
+∞
22.9
22
*
L01XX23
ATC
mitotane; oral
+∞
22.9
22
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
65.6
22.8
26
*
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
8.7
22.8
49
57
WX725
NOMESCO Finland
Noninvasive ventilation
3.1
22.6
129
431
HAE10
NOMESCO Finland
Reconstruction of breast using graft or flap
121.1
22.6
24
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
45.4
22.4
27
6
Z01.8
ICD-10 Finland
Other specified special examinations
1.7
21.9
542
3503
WA039
NOMESCO Finland
Radiotherapy with free isotopes
+∞
21.9
21
*
8010/3-C75.0
ICD-O-3
Carcinoma, NOS, of parathyroid gland
+∞
21.9
21
*
8000/3-C73.9
ICD-O-3
Neoplasm, malignant of thyroid gland
+∞
21.9
21
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
21.9
21
*
TQW20
NOMESCO Finland
Tatoe
63.1
21.9
25
*
BAA20
NOMESCO Finland
Unilateral partial excision of thyroid gland
14.6
21.6
36
25
X76
ICPC
Malignant neoplasm breast female
221.7
21.6
22
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
221.7
21.6
22
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
50.4
21.1
25
5
2504
FHL
Unilateral resection or enucleation
7.2
21.1
51
72
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
3.2
20.9
110
349
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
20.9
20
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
20.9
20
*
8020/3-C73.9
ICD-O-3
Carcinoma, undifferentiated, NOS, of thyroid gland
+∞
20.9
20
*
L01XE05
ATC
[U] sorafenib; oral
+∞
20.9
20
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
77.4
20.7
23
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
110.9
20.6
22
*
BA2MN
NOMESCO Finland
Thyroid radiation dose measurement during isotope therapy
+∞
19.8
19
*
1930X
ICD-9 Finland
Malignant neoplasm of thyroid gland[NEOPLASMA MALIGNUM THYREOIDEAE EI HISTOL VAHV]
+∞
19.8
19
*
JN5AN
NOMESCO Finland
Total body isotope imaging
+∞
19.8
19
*
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
+∞
19.8
19
*
1508
Kela drug reimbursment
Lenvatinib
+∞
19.8
19
*
3019
Kela drug reimbursment
Lenvatinib
+∞
19.8
19
*
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
5.9
19.6
55
95
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
29.2
19.6
26
9
BBA70
NOMESCO Finland
Implantation or transplantation of parathyroid gland
26.2
19.1
26
10
E05.0
ICD-10 Finland
Thyrotoxicosis with diffuse goitre
3.2
18.9
102
330
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
18.8
18
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
18.8
18
*
8010/3-C73.9
ICD-O-3
Carcinoma, NOS, of thyroid gland
+∞
18.8
18
*
C50.82
ICD-10 Finland
Overall malignant tumor of the mammary gland, lobular tumor
+∞
18.8
18
*
HA013
NOMESCO Finland
Radiotherapy after total ablation of mammary gland
+∞
18.8
18
*
1930B
ICD-9 Finland
Malignant neoplasm of thyroid gland[CARCINOMA FOLLICULARE THYREOIDEAE]
+∞
18.8
18
*
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
7.1
18.6
45
64
EP1DM
NOMESCO Finland
Very extensive MRI examination of soft tissue of neck with 3 Tesla magnet
100.8
18.6
20
*
BWD00
NOMESCO Finland
Reoperation for deep haemorrhage in endocrine surgery
100.8
18.6
20
*
L02BB03
ATC
bicalutamide; oral
191.3
18.5
19
*
BA2AT
NOMESCO Finland
Biopsy of thyroid with ultrasound quidance
38.7
18.5
23
6
S18
ICPC
Laceration/cut
1.5
18.4
900
6832
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.5
18.4
146
600
BBA40
NOMESCO Finland
Subtotal parathyroidectomy
16.3
18.3
29
18
B01AB10
ATC
tinzaparin; parenteral
2.7
18.2
128
492
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
67.1
17.7
20
*
L02BG06
ATC
exemestane; oral
+∞
17.7
17
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
17.7
17
*
Z51.0
ICD-10 Finland
Radiotherapy session
+∞
17.7
17
*
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
+∞
17.7
17
*
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
17.7
17
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
4.4
17.7
64
148
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
8.6
17.7
38
45
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
13.3
16.9
29
22
GD6BD
NOMESCO Finland
Extensive CT of chest and neck
22.0
16.8
24
11
ZX050
NOMESCO Finland
Stereotactic radiotherapy
63.7
16.7
19
*
1AB01
NOMESCO Finland
NA
+∞
16.7
16
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
16.7
16
*
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
16.7
16
*
E20.8
ICD-10 Finland
Other hypoparathyroidism
35.3
16.7
21
6
R49.01
ICD-10 Finland
Functional dysphonia
3.0
16.6
98
338
HAE20
NOMESCO Finland
Reconstruction of areola and mamilla using graft or flap
90.6
16.6
18
*
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
171.0
16.5
17
*
C90.0
ICD-10 Finland
Multiple myeloma
171.0
16.5
17
*
WW500
NOMESCO Finland
Blood transfusion
3.8
16.5
70
188
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.8
16.5
310
1831
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
5.2
16.3
50
97
SPAT1153
SPAT
Removal of sutures
1.5
16.3
685
5005
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
2.5
16.2
127
520
D35.0
ICD-10 Finland
Benign neoplasm: Adrenal gland
4.4
16.0
58
135
ZX112
NOMESCO Finland
Subcutaneous
6.6
15.8
40
61
L02AE02
ATC
leuprorelin; implant, parenteral
5.2
15.7
48
93
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
33.6
15.7
20
6
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.8
15.7
272
1561
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
+∞
15.6
15
*
E21.3
ICD-10 Finland
Hyperparathyroidism, unspecified
5.6
15.5
45
82
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.1
15.5
188
945
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
160.9
15.5
16
*
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
160.9
15.5
16
*
QX4AT
NOMESCO Finland
Ultrsound guided needle biopsy of skin
13.8
15.5
26
19
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
9.8
15.2
30
31
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
2.6
14.9
113
455
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
15.1
14.9
24
16
J01DB01
ATC
cefalexin; oral
1.5
14.8
1957
17652
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
57.0
14.8
17
*
L02BX02
ATC
degarelix; parenteral
+∞
14.6
14
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
14.6
14
*
C50.4
ICD-10 Finland
Malignant neoplasm: Upper-outer quadrant of breast
+∞
14.6
14
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
14.6
14
*
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
+∞
14.6
14
*
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
+∞
14.6
14
*
9500/3-C74.1
ICD-O-3
Neuroblastoma, NOS, of medulla of adrenal gland
+∞
14.6
14
*
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
+∞
14.6
14
*
XX9AN
NOMESCO Finland
Complementary isotope examination or additional picture
+∞
14.6
14
*
XX9XW
NOMESCO Finland
NA
7.1
14.6
35
50
KAC10
NOMESCO Finland
Total nephrectomy with capsule
36.2
14.4
18
5
WX400
NOMESCO Finland
Inhalation anesthesy
2.5
14.3
112
458
E20.9
ICD-10 Finland
Hypoparathyroidism, unspecified
27.3
14.3
19
7
H03BB01
ATC
carbimazole; oral
2.4
14.2
123
530
Z3226
NOMESCO Finland
Physiotherapist
1.6
14.2
413
2757
J01MA12
ATC
levofloxacin; systemic
1.7
14.2
350
2236
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
14.5
14.0
23
16
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
5.6
14.0
40
72
EP1CM
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with 3 Tesla magnet
17.6
13.8
21
12
Z50.5
ICD-10 Finland
Speech therapy
4.4
13.7
49
113
ZX120
NOMESCO Finland
Intravenous
2.1
13.7
168
846
XX1XN
NOMESCO Finland
Other isotope examination
+∞
13.5
13
*
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
13.5
13
*
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
13.5
13
*
L01XE29
ATC
[U] lenvatinib; oral
+∞
13.5
13
*
YG1CD
NOMESCO Finland
Very extensive CT examination of thorax for dose design of radiotherapy
+∞
13.5
13
*
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
+∞
13.5
13
*
8500/3-C50.2
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast
+∞
13.5
13
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.6
13.5
339
2174
HA1TE
NOMESCO Finland
Supplementary or limited ultrasound examination of mammary glands
8.4
13.5
29
35
ZZR10
NOMESCO Finland
Flap of skin and muscle
140.7
13.5
14
*
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
140.7
13.5
14
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
25.9
13.4
18
7
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.2
13.3
141
670
KCD02
NOMESCO Finland
Transurethral resection of bladder
11.5
13.3
24
21
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.8
13.1
218
1234
E83.50
ICD-10 Finland
Hypercalcemia
4.6
13.1
44
96
WX110
NOMESCO Finland
Local anesthesy
1.4
13.0
1583
13861
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
2.0
13.0
159
804
24199
ICD-8 Finland
Non-toxic nodular goitre, Unspecified
5.3
13.0
39
75
R4110
NOMESCO Finland
Physiotherapy
1.5
13.0
549
3987
R13
ICD-10 Finland
Dysphagia
2.1
12.9
154
771
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
3.2
12.9
68
219
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
50.2
12.8
15
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
12.5
12
*
8500/2-C50.9
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS
+∞
12.5
12
*
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
+∞
12.5
12
*
8312/3-C64.9
ICD-O-3
Renal cell carcinoma, NOS, of kidney, NOS
+∞
12.5
12
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
12.5
12
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
12.5
12
*
L01AX03
ATC
temozolomide; systemic
+∞
12.5
12
*
GBB00
NOMESCO Finland
Tracheostomy
6.7
12.5
31
47
BAA30
NOMESCO Finland
Excision of thyroid isthmus
24.4
12.5
17
7
4701
FHL
Neck lymph node removal
24.4
12.5
17
7
TPX10
NOMESCO Finland
Implantation of vascular injection port
4.0
12.4
49
125
A06AH03
ATC
naloxegol; oral
13.2
12.4
21
16
R50.9
ICD-10 Finland
Fever, unspecified
1.7
12.4
262
1600
WX720
NOMESCO Finland
Own respiration
2.5
12.4
93
373
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
3.4
12.4
58
171
2410A
ICD-9 Finland
Non-toxic nodular goitre, Non-toxic uninodular goitre
9.7
12.2
24
25
2419X
ICD-9 Finland
Non-toxic nodular goitre, Unspecified non-toxic nodular goitre
9.7
12.2
24
25
E03
ICD-10 Finland
Other hypothyroidism
2.0
12.2
157
810
R49.08
ICD-10 Finland
Other specified dysphonia
2.9
12.0
71
247
E05.9
ICD-10 Finland
Thyrotoxicosis, unspecified
2.7
12.0
83
318
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.1
11.9
135
659
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
46.9
11.9
14
*
RL210
NOMESCO Finland
NA
7.9
11.8
26
33
BB1BQ
NOMESCO Finland
Extensive scintigraphy of parathyroid gland, 2 isotopes, SPECT and low-dose CT
8.4
11.8
25
30
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.0
11.7
147
752
ZXE40
NOMESCO Finland
More than seven and less than nine hours
3.6
11.7
52
148
8720/3-C44.9
ICD-O-3
Malignant melanoma, NOS, of skin, NOS
+∞
11.5
11
*
C50.89
ICD-10 Finland
Overall malignant tumor of the mammary gland, other or undeterminated histology
+∞
11.5
11
*
C50.92
ICD-10 Finland
Malignant tumor in another specified localization in lobular gland, lobular tumor
+∞
11.5
11
*
C50.29
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology
+∞
11.5
11
*
8097/3-C44.9
ICD-O-3
Basal cell carcinoma, nodular of skin, NOS
+∞
11.5
11
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.6
11.5
51
145
C44.39
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology
120.5
11.4
12
*
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
120.5
11.4
12
*
H01CB03
ATC
lanreotide; parenteral
120.5
11.4
12
*
Z2221
NOMESCO Finland
Medical doctor
1.4
11.4
609
4610
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
3.2
11.4
59
189
T85
ICPC
Hyperthyroidism/thyrotoxicosis
7.0
11.3
27
39
HA1CG
NOMESCO Finland
Extensive MRI examination of mammary gland with high intensity magnet
8.3
11.3
24
29
R4130
NOMESCO Finland
Speech therapy
3.1
11.2
60
196
XX2AT
NOMESCO Finland
Other injection with ultrasound examination
7.3
11.2
26
36
HAB99
NOMESCO Finland
Other partial excision of mammary gland
4.7
11.0
36
77
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
43.5
10.9
13
*
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
7.8
10.9
24
31
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.9
10.8
162
884
2260A
ICD-9 Finland
Benign neoplasm of thyroid gland[NEOPLASMA BENIGNUM GLANDULAE THYREOIDEAE]
11.9
10.8
19
16
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.3
10.8
95
416
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
28.1
10.7
14
5
2397A
ICD-9 Finland
Neoplasm of unspecified nature, Endocrine glands and other parts of nervous system
28.1
10.7
14
5
HAE99
NOMESCO Finland
Other reconstruction of breast
17.9
10.7
16
9
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
12.9
10.6
18
14
HA1DG
NOMESCO Finland
Very extensive MRI examination of mammary gland with high intensity magnet
12.9
10.6
18
14
C44.11
ICD-10 Finland
Basocellular carcinoma of the skin of the eyelids including the corner of the eye
60.2
10.6
12
*
A02BC02
ATC
pantoprazole; systemic
1.3
10.6
1450
12721
XKD00
NOMESCO Finland
Uroflowmetry
1.7
10.5
213
1281
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.9
10.4
163
905
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
5.2
10.4
31
60
WW300
NOMESCO Finland
Transfer of autologic stem cells
110.4
10.4
11
*
1CD02
NOMESCO Finland
NA
+∞
10.4
10
*
C79.31
ICD-10 Finland
Secondary malignant tumor of the cerebellum
+∞
10.4
10
*
C50.20
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication
+∞
10.4
10
*
8720/3-C44.5
ICD-O-3
Malignant melanoma, NOS, of skin of trunk
+∞
10.4
10
*
8335/3-C73.9
ICD-O-3
Follicular carcinoma, minimally invasive of thyroid gland
+∞
10.4
10
*
C50.12
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,lobular tumor
+∞
10.4
10
*
BC5AQ
NOMESCO Finland
Chromaffine tissue SPECT with low dose CT
+∞
10.4
10
*
8680/3-C75.5
ICD-O-3
Paraganglioma, NOS, of aortic body and other paraganglia
+∞
10.4
10
*
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
+∞
10.4
10
*
YNB10
NOMESCO Finland
Collection of stem cells for transplant
+∞
10.4
10
*
WB133
NOMESCO Finland
Very demanding adjuvant cytostatic therapy
+∞
10.4
10
*
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
10.4
10
*
C17.9
ICD-10 Finland
Malignant neoplasm: Small intestine, unspecified
+∞
10.4
10
*
C50.22
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor
+∞
10.4
10
*
8140/3-C18.7
ICD-O-3
Adenocarcinoma, NOS, of sigmoid colon
+∞
10.4
10
*
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.3
10.4
883
7214
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
32.6
10.3
13
*
BC1CD
NOMESCO Finland
Very extensive CT of adrenal glands
8.8
10.3
21
24
EP1BG
NOMESCO Finland
MRI examination of soft tissue of neck with high intesity magnet
9.6
10.2
20
21
E34.9
ICD-10 Finland
Endocrine disorder, unspecified
7.9
10.1
22
28
E05.2
ICD-10 Finland
Thyrotoxicosis with toxic multinodular goitre
3.4
10.0
46
135
D70.82
ICD-10 Finland
Drug-induced neutropenia
10.1
10.0
19
19
EP1AE
SPAT
NA
3.6
10.0
43
120
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
40.2
10.0
12
*
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
40.2
10.0
12
*
ENB50
NOMESCO Finland
Excision of cyst or fistula of thyroglossic duct
16.8
9.9
15
9
BAA50
NOMESCO Finland
Lobectomy and resection of contralateral lobe of thyroid gland
16.8
9.9
15
9
B01AB04
ATC
dalteparin; parenteral
2.2
9.9
97
449
JDB10
NOMESCO Finland
Percutaneous gastrostomy
6.3
9.8
25
40
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
1.8
9.8
156
872
S77
ICPC
Malignant neoplasm of skin
20.1
9.8
14
7
ZZF00
NOMESCO Finland
Graft of adipose tissue
8.8
9.8
20
23
XX1AD
NOMESCO Finland
Other CT-examination
55.2
9.6
11
*
E21.0
ICD-10 Finland
Primary hyperparathyroidism
3.3
9.5
46
141
AA1BD
NOMESCO Finland
Extensive CT of head and brain
3.2
9.5
48
152
D09.3
ICD-10 Finland
Carcinoma in situ: Thyroid and other endocrine glands
+∞
9.4
9
*
HAE05
NOMESCO Finland
Reconstruction of breast using soft tissue and prosthesis
+∞
9.4
9
*
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
9.4
9
*
C34.32
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma
+∞
9.4
9
*
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
+∞
9.4
9
*
FM1FN
NOMESCO Finland
Heart function isotope examination
+∞
9.4
9
*
C18.01
ICD-10 Finland
Malignant tumor of the caecum invasive carcinoma
+∞
9.4
9
*
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
+∞
9.4
9
*
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
+∞
9.4
9
*
L01CA04
ATC
vinorelbine; systemic
+∞
9.4
9
*
C43.50
ICD-10 Finland
Malignant melanoma of the torso without histology
+∞
9.4
9
*
C82.1
ICD-10 Finland
Follicular lymphoma grade II
+∞
9.4
9
*
M01AE01
ATC
ibuprofen; systemic, rectal
1.4
9.4
2171
20409
EP1AT
NOMESCO Finland
Punction of soft tissue of neck with ultrasound guidance
21.8
9.3
13
6
D25.9
ICD-10 Finland
Leiomyoma of uterus, unspecified
1.6
9.3
218
1369
ZXC96
NOMESCO Finland
Robot assisted procedure
5.6
9.3
26
47
D11.0
ICD-10 Finland
Benign neoplasm: Parotid gland
3.3
9.3
45
138
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
3.2
9.3
47
149
Z80.8
ICD-10 Finland
Family history of malignant neoplasm of other organs or systems
13.7
9.2
15
11
C08CA01
ATC
amlodipine; oral
1.3
9.1
708
5682
UJC01
NOMESCO Finland
Scopy of lower throat
5.1
9.1
27
53
UJF32
NOMESCO Finland
Coloscopy
1.4
9.1
514
3916
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.8
9.0
155
890
M05BX04
ATC
denosumab; parenteral
2.2
9.0
91
429
GAB20
NOMESCO Finland
Median sternotomy
18.6
8.9
13
7
UDQ02
NOMESCO Finland
Direct laryngoscopy
4.5
8.8
30
68
D25.1
ICD-10 Finland
Intramural leiomyoma of uterus
1.8
8.8
147
838
C64
ICD-10 Finland
Malignant neoplasm of kidney, except renal pelvis
50.1
8.7
10
*
R49.8
ICD-10 Finland
Other and unspecified voice disturbances
3.8
8.6
35
94
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
4.6
8.6
28
61
YX8VG
NOMESCO Finland
Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy
90.3
8.4
9
*
C43.72
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip: 'superficial spreading' type
90.3
8.4
9
*
WX1CG
NOMESCO Finland
Extensive total body MRI with high intensity magnet
90.3
8.4
9
*
2502
FHL
Thyroid exploration and possible biopsy
90.3
8.4
9
*
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.8
8.4
142
812
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.3
8.4
591
4662
N05CF01
ATC
zopiclone; oral
1.3
8.3
654
5241
C81.1
ICD-10 Finland
Nodular sclerosis classical Hodgkin lymphoma
+∞
8.3
8
*
8130/2-C67.9
ICD-O-3
Papillary urothelial carcinoma, non-invasive of bladder, NOS
+∞
8.3
8
*
L01CB01
ATC
etoposide; systemic
+∞
8.3
8
*
C75.9
ICD-10 Finland
Malignant neoplasm: Endocrine gland, unspecified
+∞
8.3
8
*
L01EX08
ATC
lenvatinib; oral
+∞
8.3
8
*
C75
ICD-10 Finland
Malignant neoplasm of other endocrine glands and related structures
+∞
8.3
8
*
8380/3-C54.1
ICD-O-3
Endometrioid adenocarcinoma, NOS, of endometrium
+∞
8.3
8
*
128
Kela drug reimbursment
Cancers of female genital organs
+∞
8.3
8
*
153
Kela drug reimbursment
Lenalidomid
+∞
8.3
8
*
C50.31
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor
+∞
8.3
8
*
C18.21
ICD-10 Finland
Malignant tumor of the ascending colon invasive carcinoma
+∞
8.3
8
*
WB402
NOMESCO Finland
Demanding antibody therapy of primary tumour
+∞
8.3
8
*
L04AX04
ATC
lenalidomide; oral
+∞
8.3
8
*
L02BA03
ATC
fulvestrant; parenteral
+∞
8.3
8
*
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
+∞
8.3
8
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
8.3
8
*
8520/3-C50.4
ICD-O-3
Lobular carcinoma, NOS, of upper-outer quadrant of breast
+∞
8.3
8
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
8.3
8
*
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
+∞
8.3
8
*
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
+∞
8.3
8
*
163
Kela drug reimbursment
Abiraterone and enzalutamide
+∞
8.3
8
*
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.8
8.3
150
874
I10
ICD-10 Finland
Essential (primary) hypertension
1.3
8.3
1200
10454
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
9.5
8.3
16
17
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
4.2
8.2
29
69
R49.09
ICD-10 Finland
Unspecified dysphonia
4.0
8.1
31
79
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
33.4
8.1
10
*
J01MA02
ATC
ciprofloxacin; systemic
1.3
8.1
768
6327
UGB02
NOMESCO Finland
Tracheoscopy
11.7
8.1
14
12
D38.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Mediastinum
11.7
8.1
14
12
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
3.5
8.0
35
100
Z03.1
ICD-10 Finland
Observation for suspected malignant neoplasm
4.5
8.0
27
61
E89.00
ICD-10 Finland
Postirradiation hypothyroidism
3.7
8.0
33
90
E89.0
ICD-10 Finland
Postprocedural hypothyroidism
10.0
8.0
15
15
R59.9
ICD-10 Finland
Enlarged lymph nodes, unspecified
5.0
8.0
24
48
LCD04
NOMESCO Finland
Laparoscopic hysterectomy
2.0
8.0
95
479
LAF11
NOMESCO Finland
Laparoscopic bilateral salpingo-oophorectomy
2.0
8.0
93
466
M01AE03
ATC
ketoprofen; systemic, rectal
1.3
8.0
811
6740
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
3.2
7.9
40
128
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.7
7.9
155
927
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
7.8
7.9
17
22
A02BC05
ATC
esomeprazole; systemic
1.3
7.9
887
7473
Z3231
NOMESCO Finland
Registered nurse
1.3
7.8
534
4186
BBA20
NOMESCO Finland
Exploration of parathyroid gland
8.5
7.8
16
19
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
2.5
7.8
59
243
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
7.0
7.8
18
26
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
3.9
7.7
30
78
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
45.1
7.7
9
*
S04
ICPC
Lump/swelling localized
1.6
7.7
189
1205
GB1AA
NOMESCO Finland
Tracheal X-ray examination
18.4
7.6
11
6
DQE20
NOMESCO Finland
Implantation of foreign material in vocal chord
25.1
7.6
10
*
2533
FHL
Unilateral removal of additional egg
25.1
7.6
10
*
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.8
7.6
133
773
JFB31
NOMESCO Finland
Laparoscopic right hemicolectomy
8.9
7.5
15
17
UDC00
NOMESCO Finland
Ear microscopy
1.7
7.5
150
905
ZZR00
NOMESCO Finland
Flap of skin
5.7
7.5
20
35
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
2.0
7.4
85
424
OAB38
NOMESCO Finland
Psychosocial guidance and counselling
80.3
7.4
8
*
LCA06
NOMESCO Finland
Biopsy of endometrium
1.5
7.4
272
1906
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
7.7
7.4
16
21
N63
ICD-10 Finland
Unspecified lump in breast
1.8
7.3
114
633
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
3.2
7.3
36
114
C80.90
ICD-10 Finland
Malignant tumor without specified localization without histology
+∞
7.3
7
*
9680/3-C73.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of thyroid gland
+∞
7.3
7
*
C43.62
ICD-10 Finland
Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type
+∞
7.3
7
*
Z08.8
ICD-10 Finland
Follow-up examination after other treatment for malignant neoplasm
+∞
7.3
7
*
2374A
ICD-9 Finland
Neoplasm of uncertain behaviour of endocrine glands and nervous system, Other and unspecified endocrine glands
+∞
7.3
7
*
8370/3-C74.9
ICD-O-3
Adrenal cortical carcinoma of adrenal gland, NOS
+∞
7.3
7
*
329
Kela drug reimbursment
Lenalidomide
+∞
7.3
7
*
C83.00
ICD-10 Finland
Lymphocytic lymphoma
+∞
7.3
7
*
C34.82
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary adenocarcinoma
+∞
7.3
7
*
8140/3-C18.2
ICD-O-3
Adenocarcinoma, NOS, of ascending colon
+∞
7.3
7
*
C50.59
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, other or undeterminated histology
+∞
7.3
7
*
8140/3-C34.1
ICD-O-3
Adenocarcinoma, NOS, of upper lobe, lung
+∞
7.3
7
*
8010/3-C74.9
ICD-O-3
Carcinoma, NOS, of adrenal gland, NOS
+∞
7.3
7
*
C76.0
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Head, face and neck
+∞
7.3
7
*
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
+∞
7.3
7
*
C19
ICD-10 Finland
Malignant neoplasm of rectosigmoid junction
+∞
7.3
7
*
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
9.4
7.3
14
15
T73
ICPC
Neoplasm endocrine other/unspecified
15.8
7.2
11
7
GEB30
NOMESCO Finland
Mediastinotomy and excision of lesion
30.1
7.1
9
*
2509
FHL
Other measure in this category
20.1
7.1
10
5
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
3.5
7.1
31
90
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.1
7.1
73
350
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
3.5
7.0
30
86
TKE00
NOMESCO Finland
Needle biopsy of prostate
3.3
7.0
33
102
D48.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Breast
3.0
7.0
38
130
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.3
6.9
606
4915
TPX15
NOMESCO Finland
Removal of vascular injection port
13.8
6.9
11
8
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.6
6.8
163
1034
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.5
6.8
244
1700
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
4.2
6.8
24
58
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
40.1
6.8
8
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.6
6.7
189
1246
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
3.1
6.7
34
111
R07.0
ICD-10 Finland
Pain in throat
1.7
6.7
128
762
D44.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Endocrine gland, unspecified
22.6
6.7
9
*
R4190
NOMESCO Finland
Nutritional therapy
2.3
6.5
56
246
C07AA05
ATC
propranolol; systemic
1.3
6.5
422
3272
WX892
NOMESCO Finland
Monitored bed care
1.7
6.5
132
799
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.3
6.5
593
4829
2411A
ICD-9 Finland
Non-toxic nodular goitre, Non-toxic multinodular goitre
5.0
6.5
19
38
UJC12
NOMESCO Finland
Flexible oesophagoscopy
5.0
6.5
19
38
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
6.2
6.5
16
26
Q18.0
ICD-10 Finland
Sinus, fistula and cyst of branchial cleft
5.7
6.4
17
30
C18.20
ICD-10 Finland
Malignant tumor of the ascending colon without histology
70.0
6.4
7
*
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
70.0
6.4
7
*
A06AC01
ATC
ispaghula (psylla seeds); oral
1.3
6.4
507
4050
WF099
NOMESCO Finland
Other radiotherapy
14.3
6.4
10
7
GDB11
NOMESCO Finland
Thoracoscopic wedge resection of lung
8.2
6.3
13
16
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
1.8
6.3
104
594
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
2.7
6.3
39
145
L02AE03
ATC
goserelin; implant
4.0
6.3
23
58
N40
ICD-10 Finland
Hyperplasia of prostate
1.5
6.3
233
1637
Z43.0
ICD-10 Finland
Attention to tracheostomy
18.0
6.3
9
5
C44.10
ICD-10 Finland
Malignant tumor of the skin of the eyelids including the corner of the eye without histology
+∞
6.2
6
*
DQB60
NOMESCO Finland
Aryotenoidectomy
+∞
6.2
6
*
WB111
NOMESCO Finland
Multiple neoadjuvant cytostatic therapy
+∞
6.2
6
*
192
Kela drug reimbursment
Fulvestrant
+∞
6.2
6
*
8090/3-C44.4
ICD-O-3
Basal cell carcinoma, NOS, of skin of scalp and neck
+∞
6.2
6
*
C24.9
ICD-10 Finland
Malignant neoplasm: Biliary tract, unspecified
+∞
6.2
6
*
9591/3-C73.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of thyroid gland
+∞
6.2
6
*
189
Kela drug reimbursment
Imatinib
+∞
6.2
6
*
1501
Kela drug reimbursment
Palbociclib
+∞
6.2
6
*
1930D
ICD-9 Finland
Malignant neoplasm of thyroid gland[CARCINOMA MEDULLARE THYREOIDEAE]
+∞
6.2
6
*
BC5AN
NOMESCO Finland
Chromaffine and adrenergic tissue isotope imaging (MIBG)
+∞
6.2
6
*
TGB20
NOMESCO Finland
Tracheostomy tube replacement
+∞
6.2
6
*
L02BB04
ATC
enzalutamide; oral
+∞
6.2
6
*
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
+∞
6.2
6
*
C50.80
ICD-10 Finland
Overall malignant tumor of the mammary gland, no histological veryfication
+∞
6.2
6
*
4707
FHL
Dissection Colli radicalis
+∞
6.2
6
*
C79.7
ICD-10 Finland
Secondary malignant neoplasm of adrenal gland
+∞
6.2
6
*
L01XE01
ATC
[U] imatinib; oral
+∞
6.2
6
*
YN7AD
NOMESCO Finland
CT examination of spine for dose design of radiotherapy
+∞
6.2
6
*
HAC15
NOMESCO Finland
Subcutaneous mastectomy with excision of mamilla
+∞
6.2
6
*
WW402
NOMESCO Finland
Leucoferesis
+∞
6.2
6
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
6.2
6
*
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
+∞
6.2
6
*
D44
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of endocrine glands
+∞
6.2
6
*
C73, C75
ICD-10 Finland
NA
+∞
6.2
6
*
394
Kela drug reimbursment
Palbociclib
+∞
6.2
6
*
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
+∞
6.2
6
*
C43.70
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip without histology
+∞
6.2
6
*
D36.0
ICD-10 Finland
Benign neoplasm: Lymph nodes
+∞
6.2
6
*
WF001
NOMESCO Finland
Preoperative radiotherapy
+∞
6.2
6
*
C50.9
ICD-10 Finland
Malignant neoplasm: Breast, unspecified
+∞
6.2
6
*
C79.0
ICD-10 Finland
Secondary malignant neoplasm of kidney and renal pelvis
+∞
6.2
6
*
Z85.3
ICD-10 Finland
Personal history of malignant neoplasm of breast
+∞
6.2
6
*
C79.39
ICD-10 Finland
Secondary malignant tumor of the meninges, ventricle or other part of the brain
+∞
6.2
6
*
C50.2
ICD-10 Finland
Malignant neoplasm: Upper-inner quadrant of breast
+∞
6.2
6
*
C50.10
ICD-10 Finland
Malignant tumor of the central part of the mammary gland, no histological veryfication
+∞
6.2
6
*
C44.71
ICD-10 Finland
Basocellular carcinoma of the skin of the lower extremity including the hip
26.7
6.2
8
*
NK6BQ
NOMESCO Finland
Whole body extensive bone SPET with low dose CT
26.7
6.2
8
*
N02AX02
ATC
tramadol; systemic, rectal
1.2
6.2
845
7236
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.7
6.2
207
2864
JN3AD
NOMESCO Finland
Abdominal CT examination
1.7
6.1
123
742
E26.0
ICD-10 Finland
Primary hyperaldosteronism
5.3
6.1
17
32
EL4AT
NOMESCO Finland
Salivary gland cytology with ultrasound guidance
7.7
6.1
13
17
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
3.2
6.1
29
91
P01AB01
ATC
metronidazole; oral, rectal
1.2
6.1
884
7621
J37.0
ICD-10 Finland
Chronic laryngitis
2.0
6.1
74
379
ZXB10
NOMESCO Finland
Medial
4.9
6.0
18
37
E05.1
ICD-10 Finland
Thyrotoxicosis with toxic single thyroid nodule
10.0
6.0
11
11
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3018418) pH of Serum or Plasma
1910
7304
4.78
307.65
8.3
3.2
ph
7.4
7.4
1.80
428
1247
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
706
400
22.13
307.65
1.5
1.2
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
2580
12532
5.69
307.65
12.4
5.5
mmol/l
1.2
1.2
36.49
2173
10552
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
1789
1765
20.73
307.65
7.1
3.0
pmol/l
4.5
4.5
0.15
1737
1553
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
2035
26
2009.17
307.65
7.6
1.3
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
2390
11262
4.97
307.65
10.4
5.1
mmol/l
1.2
1.2
27.90
2296
9968
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
2015
130
390.62
307.65
7.8
1.1
u/ml
56.9
133.9
0.68
757
35
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
871
2047
5.41
307.65
3.5
3.7
ng/l
52.7
85.5
33.07
781
1753
(4035726)
762
844
11.41
307.65
1.5
1.3
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
1732
8220
3.31
249.36
4.4
2.0
mmol/l
2.3
2.4
38.49
1593
6897
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
3055
22426
5.36
185.85
11.0
4.1
pmol/l
17.5
14.7
307.65
2965
20510
(3002256) Pathology report gross observation
697
2302
3.56
172.98
1.4
1.1
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
168
154
11.44
158.82
4.0
1.6
nmol/l
5.8
3.9
0.81
163
147
(3044640) Blood type and Crossmatch panel - Blood
1414
7317
2.62
153.26
2.5
2.0
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
861
3498
2.97
148.95
4.1
2.8
mmol/l
0.8
0.8
2.14
824
3203
(40768804) Tissue Pathology biopsy report
1694
9652
2.54
148.52
2.4
1.7
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1879
11370
2.50
142.62
4.3
3.6
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1880
11702
2.39
129.26
2.9
2.3
nmol/l
78.8
78.2
0.47
1776
10429
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
433
1263
3.79
127.31
4.4
1.5
ug/l
25.2
14.3
0.32
338
940
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
90
41
22.53
122.66
3.6
1.0
u/ml
27.8
15.1
2.42
90
36
(3024561) Albumin [Mass/volume] in Serum or Plasma
1710
10394
2.33
121.73
5.6
3.8
g/l
36.1
36.1
0.01
1622
9514
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
212
367
6.10
117.83
3.1
1.2
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
216
402
5.68
111.22
3.2
1.2
nmol/l
0.4
0.4
0.04
34
24
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
528
1955
3.02
104.81
7.4
2.9
mmol/l
1.2
1.2
12.86
496
1625
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
232
499
4.92
101.33
2.6
2.8
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
904
4487
2.39
99.09
3.9
2.1
mmol/l
2.4
2.4
12.48
821
3821
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
191
356
5.63
98.05
3.1
1.3
nmol/l
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1856
12357
2.13
97.27
7.8
3.8
umol/l
10.9
11.2
0.52
1775
11505
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
2620
20013
2.45
97.27
10.0
5.5
u/l
77.6
75.7
1.63
2530
18524
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
1039
5607
2.24
92.50
2.4
2.0
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
661
3007
2.49
86.53
5.8
5.5
mmol/l
1.1
1.0
2.70
615
2773
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
3097
26211
3.57
84.94
14.2
4.9
mu/l
1.7
2.1
1.12
2974
24171
(3013650) Neutrophils [#/volume] in Blood by Automated count
2025
14489
2.01
80.66
11.0
6.8
e9/l
3.9
4.1
4.77
1786
12497
(40768795) Lymph node Pathology biopsy report
67
60
11.38
64.03
1.2
1.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
135
272
5.13
63.39
2.9
1.4
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
2014
15095
1.84
61.77
5.8
4.1
mmol/l
6.5
6.6
1.71
1918
13949
(3033658) Prothrombin time (PT) actual/Normal
1002
6081
1.93
60.11
4.2
3.4
%
94.3
92.0
2.32
987
5893
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
207
632
3.43
55.65
2.2
1.6
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
145
352
4.26
54.16
2.5
1.4
mu/l
46.6
51.0
0.15
129
314
(3036481) Cortisol [Moles/volume] in Serum or Plasma
499
2471
2.20
51.55
3.4
1.8
nmol/l
378.4
364.5
0.33
473
2246
(3032080) INR in Blood by Coagulation assay
1365
9615
1.71
47.11
8.3
8.7
inr
1.2
1.2
3.43
448
2861
(40768793) Breast Pathology biopsy report
104
224
4.76
45.14
1.3
1.2
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
44
36
12.37
44.45
1.2
1.2
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
430
2177
2.12
41.44
5.4
3.0
u/l
236.2
233.3
0.19
408
2036
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
154
483
3.29
39.58
3.0
2.0
u/ml
507.2
70.6
0.84
130
385
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
455
2433
2.01
37.60
3.5
2.9
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
454
2432
2.00
37.31
7.3
7.3
mmol/l
1.2
1.2
0.19
365
1866
(42870588) Differential panel, method unspecified - Blood
1203
8594
1.63
36.81
7.0
5.7
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
455
2456
1.99
36.55
7.3
7.3
kpa
12.9
11.9
2.96
430
2331
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
455
2456
1.99
36.55
7.3
7.3
kpa
5.1
5.1
0.67
430
2334
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
119
334
3.66
36.31
1.5
1.4
pmol/l
267.1
309.6
0.98
96
260
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
256
1113
2.41
35.44
8.7
10.7
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
410
2179
2.01
34.31
7.5
7.7
%
95.8
95.3
0.64
395
2086
(3010838) Calcium [Moles/time] in 24 hour Urine
73
148
5.02
34.04
1.9
1.9
mmol/24h
5.7
9.1
—
8
12
(40758558) Short blood count panel - Blood
909
6163
1.65
33.66
8.3
4.9
—
—
—
0
0
(3012565) Volume of 24 hour Urine
62
110
5.72
33.47
2.7
2.1
ml
1896.1
1993.9
0.29
56
96
(3023368) Bacteria identified in Blood by Culture
863
5793
1.66
33.15
4.8
3.8
—
—
—
0
0
(3044889) 12 lead EKG panel
2262
19034
1.59
32.38
4.2
3.6
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
378
1991
2.01
32.35
7.9
8.1
g/l
122.5
122.4
0.04
362
1905
(3003694) ABO and Rh group [Type] in Blood
978
6835
1.61
31.70
1.5
1.4
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
359
1886
2.01
30.89
2.0
2.2
g/l
0.2
0.2
4.37
342
1716
(3002030) Lymphocytes/100 leukocytes in Blood
1612
12669
1.53
30.74
7.2
5.9
%
27.7
28.8
3.99
1517
11725
(3006504) Eosinophils/100 leukocytes in Blood
1567
12244
1.53
30.69
7.1
5.8
%
2.8
2.9
2.15
1481
11318
(3019069) Monocytes/100 leukocytes in Blood
1575
12323
1.53
30.63
7.4
6.1
%
8.6
8.4
1.60
1490
11463
(3022096) Basophils/100 leukocytes in Blood
1524
11864
1.52
30.19
7.2
5.9
%
0.7
0.7
1.29
1438
10969
(3019198) Lymphocytes [#/volume] in Blood
1699
13580
1.51
29.41
6.8
5.7
e9/l
1.9
1.9
0.11
1501
11953
(3001604) Monocytes [#/volume] in Blood
1650
13178
1.50
28.20
6.7
5.6
e9/l
0.6
0.6
0.06
1429
11374
(3019550) Sodium [Moles/volume] in Serum or Plasma
3075
28405
2.07
27.90
20.0
13.3
mmol/l
139.8
139.8
0.14
3031
27645
(3006315) Basophils [#/volume] in Blood
1653
13245
1.49
27.56
6.8
5.7
e9/l
0.0
0.0
1.96
1433
11423
(3013115) Eosinophils [#/volume] in Blood
1702
13732
1.49
27.33
7.1
5.8
e9/l
0.2
0.2
0.81
1507
12075
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
62
135
4.66
26.62
1.3
1.4
umol/l
4.0
4.3
0.20
55
127
(3023103) Potassium [Moles/volume] in Serum or Plasma
3077
28505
2.04
26.51
20.4
13.4
mmol/l
3.9
4.0
16.60
3021
27689
(3002385) Erythrocyte distribution width [Ratio]
2601
23009
1.59
26.39
23.5
13.8
%
13.6
13.6
0.30
2571
22469
(3018010) Neutrophils/100 leukocytes in Blood
1571
12559
1.47
25.87
7.0
5.7
%
57.6
56.7
1.99
1480
11665
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
179
764
2.42
25.74
1.9
1.9
iu/l
5.2
4.5
0.39
79
285
(3047181) Lactate [Moles/volume] in Blood
170
728
2.41
24.27
4.9
7.0
mmol/l
1.3
1.2
0.32
149
630
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
2989
27563
1.82
24.13
18.3
11.5
mg/l
20.9
21.1
0.19
2501
21066
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
254
1302
2.03
23.25
10.3
7.8
mmol/l
25.1
24.8
0.78
249
1296
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
98
327
3.06
22.77
1.3
1.3
—
37.0
—
0
5
(3026782) Osmolality of Urine
682
4709
1.56
22.03
2.6
2.6
mosm/kgh2o
526.7
535.4
0.49
586
3933
(3021589) Normoblasts [#/volume] in Blood
1465
11789
1.43
22.02
12.9
8.1
e9/l
0.0
0.0
0.48
1222
9608
(3014576) Chloride [Moles/volume] in Serum or Plasma
434
2678
1.71
22.02
8.5
6.2
mmol/l
104.3
104.3
0.03
424
2619
(3018677) aPTT in Platelet poor plasma by Coagulation assay
541
3587
1.61
20.66
2.8
2.1
s
30.0
29.7
0.53
528
3457
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
235
1226
1.99
20.44
2.4
1.5
u/ml
43.5
25.2
1.06
228
1170
(3000991) Gas panel - Venous blood
317
1824
1.82
20.43
9.6
7.9
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
898
6664
1.48
20.39
3.2
2.8
—
—
—
0
0
(3039000) Anion gap in Blood
123
492
2.56
20.35
5.5
8.5
mmol/l
11.2
11.2
0.02
113
432
(3018572) Chloride [Moles/volume] in Blood
123
493
2.55
20.26
5.5
8.5
mmol/l
105.6
104.8
1.59
113
433
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
100
364
2.80
19.91
1.4
1.5
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
1145
8934
1.43
19.80
3.8
3.4
e6/l
74.3
105.8
0.89
828
6090
(3002582) Erythrocytes [#/volume] in Urine
974
7383
1.45
19.68
3.4
3.0
e6/l
50.3
66.7
0.52
754
5555
(3042936) Bacteria identified in Isolate by Culture
491
3233
1.61
19.20
2.0
2.0
—
—
—
0
0
(3036603) Volume of Urine
54
137
3.99
19.12
1.6
1.4
ml
2148.4
2008.8
—
10
23
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
146
651
2.30
19.04
2.3
2.9
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
81
269
3.06
19.02
1.5
1.4
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
37
70
5.33
18.71
1.5
1.1
umol/24h
37.7
0.7
0.51
20
36
(3013707) Erythrocyte sedimentation rate by Westergren method
2336
20743
1.42
18.38
4.5
4.1
mm/h
12.3
11.4
2.26
2182
19223
(3045142) Bone marrow Pathology biopsy report
57
155
3.72
18.33
1.5
1.2
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
50
124
4.08
18.27
2.5
2.1
%
14.8
12.8
0.47
25
60
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
209
1094
1.97
18.00
10.2
9.1
mmol/l
24.5
24.4
0.30
198
1008
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
478
3173
1.59
17.99
2.9
2.6
%
21.9
23.1
0.99
390
2679
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
2810
25899
1.54
17.87
17.9
10.3
ml/min/173m2
83.2
81.6
3.94
2475
20797
(3008152) Bicarbonate [Moles/volume] in Arterial blood
249
1389
1.86
17.70
6.1
7.2
mmol/l
25.1
24.6
1.22
232
1272
(3011412) CD3 cells [#/volume] in Blood
58
164
3.58
17.63
3.2
2.3
e9/l
1.2
1.2
0.01
38
94
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
49
123
4.03
17.62
1.7
1.8
nmol/l
7.5
7.4
0.01
42
95
(3000850) Epithelial cells [#/volume] in Urine
712
5180
1.48
17.48
2.7
2.4
e6/l
4.8
6.3
3.34
623
4483
(3020779) Urea [Moles/volume] in Serum or Plasma
316
1902
1.73
17.39
9.1
7.6
mmol/l
9.2
9.5
0.42
296
1813
(3019225) pH of Specimen
397
2541
1.64
17.32
9.2
3.5
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
895
6812
1.43
17.26
3.3
2.9
e6/l
0.4
0.4
0.05
694
5060
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1083
8541
1.40
16.99
3.9
2.7
u/l
28.6
34.3
1.95
1027
8082
(3019060) Gas panel - Arterial blood
254
1445
1.82
16.94
4.4
5.3
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
2025
17714
1.36
16.29
4.7
4.3
e6/l
1495.0
1924.3
0.14
30
221
(3002032) Base excess in Venous blood by calculation
344
2160
1.66
16.14
5.7
3.6
mmol/l
2.0
2.0
0.16
271
1785
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
530
3687
1.52
16.06
2.1
1.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
393
2561
1.61
15.89
1.9
1.7
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
21
8
26.40
15.57
1.1
1.1
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
46
121
3.84
15.55
2.6
2.1
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
502
3480
1.52
15.42
2.8
2.4
g/l
2.4
2.4
0.33
467
3210
(3022948) Iron [Moles/volume] in Serum or Plasma
543
3840
1.49
15.14
2.8
2.4
umol/l
12.5
13.6
2.63
511
3528
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
62
202
3.11
15.11
1.2
1.0
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
388
2563
1.58
14.77
1.9
1.7
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
3058
28978
1.67
14.72
18.1
11.1
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
338
2166
1.62
14.60
5.8
3.6
kpa
5.8
5.9
0.08
326
2105
(3014111) Lactate [Moles/volume] in Serum or Plasma
305
1916
1.65
14.25
10.0
6.6
mmol/l
1.2
1.4
2.00
292
1849
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
407
2748
1.55
14.05
2.9
2.4
umol/l
7.4
6.9
0.17
357
2329
(21494815) CD4 cells/100 lymphocytes in Specimen
48
141
3.44
13.84
2.6
2.2
%
40.3
46.6
—
6
19
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
264
1621
1.68
13.46
1.7
1.6
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
43
122
3.56
13.08
1.7
1.6
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
333
2183
1.58
13.05
4.1
3.8
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1011
8160
1.34
12.92
2.8
2.3
u/l
58.8
57.5
0.15
935
7460
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
830
6513
1.37
12.71
2.4
2.2
mg/l
3.0
2.9
0.97
717
5563
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
170
936
1.86
12.62
4.8
5.6
%
1.7
1.6
0.33
160
869
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
24
44
5.49
12.58
1.4
1.4
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1422
12086
1.31
12.50
3.3
2.8
ug/l
118.3
102.8
1.79
1312
11211
(3005719) IgG [Mass/volume] in Serum or Plasma
289
1851
1.61
12.48
3.8
2.4
g/l
10.5
10.6
0.17
265
1692
(3000060) B lymphocytes [#/volume] in Blood
25
48
5.24
12.48
3.3
2.0
e6/l
272.9
177.3
0.47
14
30
(3007930) Methemoglobin/Hemoglobin.total in Blood
168
928
1.85
12.35
4.8
5.7
%
0.9
0.9
0.83
158
864
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
60
219
2.77
12.02
1.3
1.2
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
101
477
2.15
11.57
3.4
3.7
%
58.2
56.9
0.41
101
477
(3026008) Bacteria identified in Urine by Culture
985
8037
1.32
11.38
3.0
3.0
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
57
209
2.76
11.34
1.9
1.5
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
199
1186
1.72
11.34
2.3
2.2
nmol/l
10.2
13.5
5.84
176
1038
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
40
120
3.36
11.22
3.8
2.1
e9/l
0.2
0.2
0.42
32
105
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
41
125
3.31
11.21
3.7
2.1
e6/l
491.0
442.0
0.29
32
106
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
119
607
2.00
11.12
7.1
4.1
mg/l
1.5
1.5
0.03
113
549
(3027945) Reticulocytes/100 erythrocytes in Blood
361
2496
1.50
11.07
3.5
2.3
%
1.8
1.8
0.04
327
2190
(40760888) Immunoglobulin light chains.free panel - Serum
102
493
2.10
11.03
3.7
1.4
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
280
1836
1.57
10.94
3.0
2.3
e9/l
71.2
70.6
0.09
205
1382
(3006245) CD3-CD19+ cells/100 cells in Blood
29
71
4.11
10.86
3.1
2.0
%
14.6
11.3
0.50
24
65
(3004809) Band form neutrophils/100 leukocytes in Blood
67
273
2.48
10.82
4.0
3.0
%
2.0
1.0
1.15
55
207
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
645
4976
1.37
10.78
3.9
3.6
ng/l
150.5
458.8
3.94
480
3681
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
20
36
5.58
10.69
1.5
1.1
umol/24h
21.0
1.7
0.53
20
36
(3017181) Myelocytes/100 leukocytes in Blood
301
2017
1.54
10.69
4.4
4.0
%
1.4
0.6
3.41
95
405
(40760892) CBC W Ordered Manual Differential panel - Blood
751
5941
1.34
10.64
4.7
4.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
87
401
2.20
10.62
2.0
1.2
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
98
474
2.10
10.59
2.2
1.4
—
—
—
0
0
(3010421) pH of Blood
112
570
2.00
10.55
4.5
3.7
ph
7.4
7.4
0.57
93
470
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
119
620
1.95
10.49
2.6
4.0
u/ml
0.3
0.4
0.63
72
356
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
26
61
4.29
10.29
3.3
2.7
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
309
2102
1.52
10.23
1.2
1.2
iu/ml
139.9
152.4
0.22
120
808
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
117
612
1.94
10.20
1.9
1.7
—
—
—
0
0
(3012501) Base excess in Blood by calculation
97
475
2.07
10.16
4.9
4.0
mmol/l
2.3
2.5
0.26
68
315
(3021440) Promyelocytes/100 leukocytes in Blood
289
1942
1.53
10.13
4.4
4.1
%
0.2
0.1
1.27
88
375
(40768800) Prostate Pathology biopsy report
32
89
3.62
10.08
1.2
1.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
391
2799
1.45
10.03
1.4
1.3
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
278
1867
1.53
9.77
3.5
1.5
g/l
66.5
67.1
0.59
257
1669
(3042631) Mycobacterium sp identified in Specimen
62
259
2.42
9.53
3.3
3.2
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
103
529
1.98
9.49
3.8
4.5
kpa
8.6
8.4
0.44
96
494
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
498
3757
1.38
9.46
3.0
2.7
e6/l
4.0
3.3
0.48
261
1965
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
539
4125
1.37
9.37
2.9
2.5
e6/l
6.3
1.2
0.46
297
2328
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
93
464
2.03
9.30
2.3
1.5
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
275
1866
1.52
9.21
4.0
3.9
%
1.4
0.5
1.29
61
309
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
40
136
2.96
9.18
1.5
1.3
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
81
387
2.12
9.09
5.0
5.7
iu/ml
1170.1
372.0
0.55
11
53
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
21
46
4.59
9.05
1.5
1.7
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
221
1436
1.58
9.00
5.2
3.0
g/l
125.8
130.9
2.57
213
1392
(3028026) IgM [Mass/volume] in Serum or Plasma
223
1453
1.57
8.98
2.3
1.5
g/l
1.4
1.3
0.28
205
1331
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
82
396
2.10
8.96
1.2
1.3
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
182
1130
1.65
8.94
3.2
3.0
mmol/l
25.8
25.5
0.56
173
1091
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
71
326
2.20
8.81
2.4
1.5
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
74
347
2.16
8.72
1.7
1.4
nmol/l
0.3
0.4
1.54
57
286
(3021901) Oxygen saturation in Capillary blood
79
381
2.10
8.67
3.0
2.9
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
119
662
1.83
8.64
3.9
1.5
ratio
1.1
1.5
—
7
63
(3025159) Blasts/100 leukocytes in Blood
272
1869
1.50
8.58
4.4
4.1
%
0.2
0.3
0.16
71
335
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
122
686
1.81
8.56
4.0
1.5
mg/l
28.1
39.5
0.72
96
549
(3034860) Kappa light chains.free [Mass/volume] in Serum
122
687
1.81
8.52
4.1
1.5
mg/l
41.3
40.3
0.08
96
553
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
12
16
7.52
8.41
4.6
1.4
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
61
271
2.27
8.22
1.9
1.4
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
2047
18738
1.24
8.06
4.7
4.2
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
34
114
3.00
8.03
1.4
1.5
—
—
—
0
0
(3013512) EKG study
901
7541
1.27
8.03
3.5
3.7
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
299
2129
1.44
7.87
3.4
3.0
ng/l
174.0
181.5
0.12
271
1929
(40767503) Oxygen content in Capillary blood by calculation
87
451
1.95
7.87
2.6
2.5
%
15.6
16.5
1.05
51
230
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
60
270
2.24
7.86
3.3
1.9
u/ml
640.9
105.6
0.65
54
243
(3028308) Erythrocytes [#/volume] in Pleural fluid
40
149
2.71
7.82
1.5
1.6
e6/l
24243.6
85274.5
0.78
25
91
(3007853) Bacteria identified in Skin by Aerobe culture
391
2924
1.38
7.79
1.7
1.7
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
123
717
1.74
7.67
3.5
3.2
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1977
18082
1.23
7.63
3.3
2.9
u/l
46.1
41.6
1.72
1841
16778
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
57
255
2.26
7.58
1.1
1.2
u/l
84.4
59.3
0.87
45
175
(3023323) Follitropin [Units/volume] in Serum or Plasma
206
1377
1.53
7.43
1.5
1.4
iu/l
29.6
28.5
0.19
175
1204
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
7
0
+∞
7.29
1.3
0.0
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
312
2271
1.41
7.28
2.6
2.2
u/l
36.0
58.0
0.49
267
1918
(3015235) Bicarbonate [Moles/volume] in Capillary blood
100
558
1.82
7.25
3.1
3.5
mmol/l
25.2
24.9
0.27
91
490
(21494814) CD8 cells/100 lymphocytes in Specimen
22
60
3.68
7.18
1.7
2.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
632
5125
1.29
7.18
1.5
1.5
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
2677
25385
1.28
7.13
21.3
12.7
%
39.6
39.8
0.52
1929
18414
(3041096) Erythrocytes [Presence] in Urine by Automated
853
7184
1.25
7.06
3.4
3.2
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
38
146
2.62
7.03
2.1
1.4
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
111
645
1.75
7.03
3.8
2.8
g/l
3.5
3.5
0.21
104
603
(1616796) Gas panel - Central venous blood
87
471
1.87
6.96
4.7
3.6
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
172
1123
1.56
6.92
7.9
4.0
mmol/l
24.2
24.2
0.00
157
1008
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
148
933
1.61
6.90
2.2
2.0
u/l
8809.7
4602.4
0.41
33
380
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
115
682
1.71
6.79
2.9
2.5
%
180.2
180.3
0.00
107
645
(3004588) Protein electrophoresis panel - Serum or Plasma
232
1622
1.46
6.75
3.0
1.4
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
1508
13545
1.21
6.55
3.9
3.6
estimate
0.0
0.0
1.32
330
2319
(3023199) Leukocytes [#/volume] in Pleural fluid
41
170
2.43
6.51
1.4
1.5
e6/l
2943.7
2617.5
0.07
32
129
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
15
33
4.56
6.45
1.1
1.2
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
124
763
1.65
6.40
2.5
1.8
ug/l
14.1
1.7
0.53
107
660
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
172
1147
1.53
6.32
2.2
1.9
u/l
36.9
39.2
0.85
148
1014
(3009214) Lutropin [Units/volume] in Serum or Plasma
106
628
1.71
6.31
2.0
1.5
u/l
13.7
10.8
1.01
79
512
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
956
8240
1.22
6.26
2.3
2.1
u/l
162.5
195.9
0.87
917
7698
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
18
47
3.85
6.25
1.8
2.4
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
33
126
2.64
6.22
3.9
2.2
e6/l
672.8
793.8
0.37
13
55
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
84
468
1.82
6.18
1.6
1.4
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
35
139
2.53
6.10
1.6
1.6
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
1487
13408
1.20
6.01
5.2
4.8
estimate
0.0
0.0
0.80
328
2363
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
28
101
2.79
5.88
2.1
1.4
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
28
102
2.76
5.78
2.1
1.4
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
706
5938
1.24
5.77
2.1
1.8
mg/l
1.2
1.0
0.46
536
4448
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
23
75
3.08
5.76
1.3
1.2
pmol/l
413.5
262.4
0.48
17
48
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
17
46
3.71
5.64
2.8
1.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
67
360
1.88
5.56
1.8
1.4
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
118
745
1.61
5.54
2.8
2.4
%
95.3
93.0
0.58
113
690
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
11
21
5.25
5.52
1.5
1.4
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
44
204
2.17
5.47
1.2
1.1
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
1472
13346
1.18
5.39
3.9
3.6
estimate
0.0
0.0
0.50
331
2328
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
14
34
4.13
5.35
1.3
1.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
34
143
2.39
5.30
1.5
1.5
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
111
699
1.61
5.28
2.4
2.0
mg/l
11.4
11.2
0.08
101
639
(3001019) Free T4 and TSH panel - Serum or Plasma
219
1588
1.41
5.27
2.3
1.7
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
260
3431
0.74
5.23
4.5
4.6
%
32.6
32.8
0.11
177
2317
(3049717) Cytology report of Urine Cyto stain
107
670
1.62
5.22
2.8
1.8
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
76
434
1.77
5.21
1.4
1.6
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
29
114
2.56
5.20
2.1
1.3
—
—
—
0
0
(3017704) Immunofixation for Urine
30
121
2.49
5.12
1.5
1.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
462
3753
1.27
5.09
1.3
1.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1107
9835
1.19
5.04
3.6
3.4
ng/l
45.8
53.0
0.22
722
6265
(3036489) Thrombin time
136
909
1.52
5.01
2.6
2.1
s
21.5
21.0
0.49
122
774
(3037522) Nuclear Ab [Titer] in Serum
490
4018
1.26
4.98
1.4
1.3
titre
447.9
566.2
1.07
91
878
(3017143) Hepatitis C virus Ab [Presence] in Serum
351
2763
1.30
4.95
1.7
1.5
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
31
130
2.40
4.88
1.2
1.1
u/l
116.7
75.0
0.43
23
92
(3007164) IgA [Mass/volume] in Serum or Plasma
651
5524
1.22
4.82
1.7
1.3
g/l
2.3
2.4
0.09
418
3269
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
141
959
1.49
4.79
1.9
1.6
g/l
1.6
1.5
0.14
121
822
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
73
423
1.74
4.79
1.5
1.4
u/ml
104.7
109.4
0.19
17
73
(21494890) Protein electrophoresis panel - 24 hour Urine
40
189
2.13
4.78
1.8
1.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
53
278
1.92
4.78
1.8
1.3
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
74
432
1.73
4.73
1.9
1.6
g/l
0.8
0.8
0.09
51
327
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
34
151
2.26
4.72
1.6
1.4
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
58
315
1.86
4.71
3.1
2.6
—
—
—
0
0
(3035880) pH of Pleural fluid
21
75
2.81
4.55
1.2
1.4
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
30
129
2.34
4.50
1.2
1.1
u/l
62.7
16.7
0.43
21
87
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
34
155
2.21
4.46
1.7
1.5
u/l
8.1
6.4
0.23
16
69
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
76
457
1.68
4.39
1.3
1.6
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
20
71
2.83
4.38
2.3
1.1
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
237
1803
1.34
4.28
6.6
3.1
kpa
5.0
4.6
1.11
227
1750
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
75
453
1.67
4.27
1.3
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
75
453
1.67
4.27
1.3
1.3
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
100
649
1.56
4.26
1.3
1.3
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
3036
29592
1.29
4.25
13.2
8.8
u/l
24.9
25.2
0.57
2957
28432
(3026493) Urate [Moles/volume] in Serum or Plasma
783
6845
1.19
4.17
2.8
2.2
umol/l
2166.6
4976.1
2.03
682
5890
(3003181) Sodium [Moles/volume] in Urine
73
441
1.67
4.17
1.4
1.4
mmol/l
62.5
64.1
0.11
55
360
(3024928) Oxygen saturation in Venous blood
78
480
1.64
4.15
9.5
3.0
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
32
147
2.19
4.14
1.4
1.8
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
40
201
2.00
4.12
6.3
3.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1144
10337
1.16
4.03
4.1
3.8
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
48
261
1.85
3.94
1.5
1.2
ug/l
2.1
2.8
0.74
37
228
(40765096) Chromosome analysis panel by Banding
13
38
3.43
3.90
1.2
1.0
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
8
11
7.29
3.86
1.7
1.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
32
152
2.12
3.84
1.0
1.4
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
23
95
2.43
3.80
5.6
4.9
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
326
2639
1.26
3.72
1.4
1.4
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
147
1062
1.40
3.70
6.1
2.6
%
0.7
0.7
0.07
140
1016
(3048929) Epstein Barr virus Ab [Presence] in Serum
112
770
1.47
3.69
1.4
1.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
521
4441
1.21
3.64
1.9
1.8
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
800
7078
1.17
3.64
3.0
3.0
ng/l
1475.0
1215.1
0.49
678
5975
(3004451) EKG impression Narrative
25
110
2.28
3.61
1.2
1.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
47
262
1.81
3.60
2.0
1.3
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
856
7626
1.16
3.56
1.8
1.6
mmol/l
1.4
1.4
0.01
718
6412
(3021879) Hepatitis B virus core Ab [Presence] in Serum
221
1714
1.31
3.54
1.4
1.4
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
3157
31017
1.34
3.50
28.8
17.1
e9/l
258.4
256.5
0.91
3108
30176
(3024731) MCV [Entitic volume]
3158
31034
1.34
3.44
28.6
17.1
fl
90.1
90.8
17.71
3134
30559
(3035941) MCH [Entitic mass]
3158
31036
1.34
3.42
28.6
17.0
pg
30.0
30.2
15.65
3134
30559
(3000963) Hemoglobin [Mass/volume] in Blood
3159
31050
1.33
3.40
28.9
17.2
g/l
134.5
135.5
3.94
3135
30570
(44790049)
44
245
1.81
3.40
1.6
1.4
—
—
—
0
0
(44790047)
44
245
1.81
3.40
1.6
1.4
—
—
—
0
0
(44806118)
44
245
1.81
3.40
1.6
1.4
—
—
—
0
0
(44790048)
44
245
1.81
3.40
1.6
1.4
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
53
312
1.71
3.39
2.0
1.3
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
3158
31041
1.33
3.38
28.7
17.1
e12/l
4.5
4.5
0.74
3102
30089
(3010813) Leukocytes [#/volume] in Blood
3158
31046
1.33
3.33
28.8
17.2
e9/l
6.5
6.6
1.03
3104
30088
(3021960) Folate [Moles/volume] in Serum or Plasma
697
6144
1.17
3.30
1.5
1.5
nmol/l
21.3
21.1
0.08
623
5195
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
120
858
1.41
3.25
1.5
1.7
g/l
0.3
0.2
1.38
109
806
(40758292) HTLV I+II Ab panel - Serum
9
19
4.75
3.23
2.0
1.3
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
28
136
2.07
3.22
1.1
1.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
800
7143
1.16
3.19
4.3
4.0
estimate
0.0
0.0
1.28
314
2351
(4062490)
48
281
1.72
3.15
1.7
1.4
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
78
516
1.52
3.14
1.4
1.3
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
18
73
2.47
3.12
1.4
2.9
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
48
283
1.71
3.08
1.7
1.4
g/l
2.6
2.8
0.19
30
197
(3024139) IgG subclass 3 [Mass/volume] in Serum
48
283
1.71
3.08
1.7
1.4
g/l
0.3
0.4
0.50
29
197
(3027135) IgG subclass 1 [Mass/volume] in Serum
48
284
1.70
3.05
1.7
1.4
g/l
7.1
6.7
0.28
28
198
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
8
16
5.01
3.05
6.3
1.4
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
16
62
2.59
3.04
1.2
1.2
—
—
—
0
0
(4281824)
32
167
1.93
3.04
1.1
1.1
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
121
879
1.39
3.02
1.5
1.7
g/l
1.2
1.2
0.02
111
822
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
5
5
10.01
2.98
9.6
1.0
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
105
746
1.42
2.97
1.4
1.4
ug/g
321.1
308.3
0.30
61
405
(3020891) Body temperature
125
916
1.38
2.96
4.5
4.4
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
254
2056
1.25
2.94
3.4
2.3
ml/min/173m2
64.2
68.1
0.91
114
790
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
6
9
6.68
2.86
1.0
1.1
%
1.4
1.3
—
6
9
(3021387) Prolactin [Units/volume] in Serum or Plasma
127
939
1.37
2.86
2.0
1.6
mu/l
321.6
304.0
0.22
119
842
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
119
872
1.38
2.84
2.8
1.4
g/l
9.9
10.4
0.72
95
719
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
170
1317
1.31
2.80
1.5
1.5
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
22
103
2.14
2.80
2.7
2.4
%
41.4
46.3
—
7
41
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
26
130
2.01
2.80
1.7
1.3
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
192
1512
1.29
2.80
4.5
4.1
kpa
5.2
5.2
0.05
178
1402
(3011648) Oxygen content in Venous blood
34
188
1.82
2.74
16.3
2.5
%
10.8
11.1
0.18
34
188
(3000494) Fungus identified in Specimen by Culture
370
3141
1.20
2.72
1.7
1.4
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
45
271
1.67
2.71
1.6
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
25
125
2.01
2.70
1.7
1.3
—
—
—
0
0
(3009343) pH of Capillary blood
189
1493
1.28
2.70
4.5
4.1
ph
7.4
7.4
0.12
39
164
(3006184) Hemoglobin [Mass/volume] in Capillary blood
76
524
1.46
2.57
2.5
2.2
g/l
122.1
131.2
2.12
64
375
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
182
1443
1.28
2.54
4.5
4.1
mmol/l
2.5
1.7
2.34
149
1079
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
35
201
1.75
2.52
2.4
1.5
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1210
11245
1.12
2.52
2.0
1.9
pmol/l
94.3
97.2
1.16
605
5554
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
124
935
1.34
2.50
2.8
1.4
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
124
936
1.34
2.49
2.8
1.4
g/l
7.4
7.4
0.13
86
688
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
124
936
1.34
2.49
2.8
1.4
g/l
3.7
3.8
0.41
83
658
(3003327) Ova and parasites identified in Stool by Light microscopy
123
929
1.34
2.46
1.6
1.8
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
656
5881
1.14
2.44
1.7
1.6
pmol/l
452.9
41262174.9
6.11
525
4898
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
39
234
1.67
2.42
1.3
1.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
38
227
1.68
2.39
2.4
1.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
60
401
1.51
2.38
1.3
1.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
183
1465
1.26
2.38
2.4
2.4
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
14
58
2.42
2.36
3.1
1.2
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
32
183
1.76
2.35
4.3
2.8
%
57.1
57.9
0.05
19
121
(3017732) Neutrophils [#/volume] in Blood
233
1922
1.23
2.33
2.7
2.7
e9/l
3.9
4.1
0.69
195
1490
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
19
91
2.09
2.32
3.3
1.4
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
19
91
2.09
2.32
3.3
1.4
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
19
91
2.09
2.32
3.3
1.4
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
19
91
2.09
2.32
3.3
1.4
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
70
486
1.45
2.32
1.4
1.3
u/ml
292.3
259.0
0.46
43
291
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
22
112
1.97
2.30
3.0
1.7
u/l
177.7
192.3
0.57
22
112
(3043409) Potassium [Moles/volume] in Arterial blood
91
664
1.38
2.29
3.9
4.0
mmol/l
3.8
3.9
0.13
84
629
(3037121) Protein [Mass/volume] in Urine
109
819
1.34
2.28
4.3
2.9
g/l
0.2
0.3
2.84
57
267
(3051651) Icteric interference index of Serum or Plasma
23
120
1.92
2.25
6.5
4.0
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
421
3678
1.17
2.24
1.7
1.6
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
39
240
1.63
2.22
1.5
1.5
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
89
651
1.38
2.21
1.3
1.2
u/ml
14.9
42.8
—
9
75
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
55
369
1.50
2.17
1.3
1.2
u/l
18.9
24.5
0.56
49
314
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
39
242
1.62
2.16
1.3
1.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
599
5381
1.14
2.16
5.4
3.7
ug/l
2.4
1.9
2.10
534
4822
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
19
94
2.03
2.15
1.1
1.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
40
250
1.61
2.15
2.6
2.4
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
9
30
3.01
2.14
3.8
2.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
63
436
1.45
2.14
1.3
1.5
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
5
10
5.01
2.07
7.6
1.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
924
8538
1.11
2.07
3.3
3.2
mmol/l
7.1
7.3
0.56
781
7198
(3048689) Calprotectin [Mass/mass] in Stool
405
3552
1.16
2.06
2.4
2.3
ug/g
122.5
116.7
0.16
316
2795
(3024891) Influenza virus A+B Ag [Presence] in Specimen
89
660
1.36
2.06
1.1
1.2
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
6
15
4.00
2.04
3.3
3.3
u/l
266.7
412.3
—
6
15
(21494434) Karyotype in Bone marrow
29
169
1.72
2.03
1.2
1.2
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
84
1127
0.74
2.03
1.4
1.5
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
7
177
0.39
2.02
1.3
1.3
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
62
434
1.44
2.01
1.8
2.9
umol/l
26.1
35.6
3.18
52
384
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
61
427
1.44
1.98
1.3
1.2
u/ml
2.1
3.7
0.94
19
137
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
585
5281
1.13
1.95
1.4
1.4
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
12
51
2.36
1.95
1.2
1.4
ng/l
61.0
106.5
1.65
12
51
(3032868) Hemoglobin electrophoresis panel in Blood
8
27
2.97
1.93
1.8
1.5
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
60
421
1.43
1.93
1.3
1.2
u/ml
4.9
5.4
0.10
27
174
(3045414) Leukocytes [Presence] in Urine
97
1263
0.76
1.92
1.9
1.9
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
2718
27754
0.89
1.92
4.4
4.4
mmol/l
1.5
1.5
5.53
2531
25722
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
13
58
2.25
1.90
5.1
2.4
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
23
128
1.80
1.89
1.5
1.6
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
113
880
1.29
1.89
2.9
1.4
g/l
3.0
3.1
0.13
86
672
(3020393) Adenovirus Ag [Presence] in Stool
9
35
2.58
1.80
1.6
1.7
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
36
231
1.56
1.78
5.4
3.4
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
714
6557
1.11
1.78
1.3
1.3
u/ml
1.9
1.8
0.08
192
1778
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
105
819
1.29
1.76
1.1
1.1
u/ml
2.1
5.7
1.58
16
100
(3025941) Bacteria identified in Stool by Culture
186
1550
1.21
1.75
1.3
1.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
60
430
1.40
1.75
1.1
1.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
2622
26790
0.90
1.72
4.0
3.9
mmol/l
1.3
1.3
1.38
2424
24645
(3007566) Smooth muscle Ab [Titer] in Serum
95
734
1.30
1.71
1.2
1.2
titre
80.0
89.9
0.28
12
68
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
5
13
3.85
1.71
1.0
1.0
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
25
148
1.69
1.70
1.4
1.2
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
15
75
2.00
1.69
1.3
1.1
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
16
82
1.96
1.69
1.2
1.3
—
—
—
0
0
(1002224) Polysomnography panel
142
1156
1.24
1.68
1.0
1.1
—
—
—
0
0
(3003338) MCHC [Mass/volume]
2450
23868
1.10
1.67
25.1
15.0
g/l
332.1
332.1
0.03
2438
23709
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
28
173
1.62
1.63
2.8
1.4
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
28
173
1.62
1.63
2.8
1.4
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
28
173
1.62
1.63
2.8
1.4
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
11
49
2.25
1.63
1.7
2.8
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
108
856
1.27
1.62
1.3
1.3
u/ml
11.3
51.4
—
8
49
(3030313) Adrenal Ab [Titer] in Serum
5
14
3.58
1.61
1.0
1.1
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
18
98
1.84
1.61
1.0
1.2
%
122.4
110.5
1.10
18
86
(21494755) Public health laboratory ask at order entry panel
224
2608
0.85
1.60
1.3
1.3
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
85
1095
0.77
1.60
1.5
1.5
—
—
—
0
0
(40768443) Skin Pathology biopsy report
132
1076
1.24
1.56
1.3
1.2
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
2744
27932
0.90
1.53
4.5
4.4
mmol/l
4.7
4.8
1.53
2574
26037
(3022475) Manganese [Moles/volume] in Blood
5
15
3.34
1.52
1.2
1.0
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
79
607
1.31
1.52
1.5
1.3
e6/l
38.0
27.5
0.23
51
473
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
79
609
1.30
1.49
1.5
1.4
e6/l
948.8
1313.1
0.21
57
501
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
216
1856
1.18
1.48
1.3
1.3
au/ml
62.4
47.2
0.28
11
79
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
475
4310
1.12
1.48
4.7
3.6
%
22.3
24.1
1.69
243
1922
(3044290) Cell count panel - Cerebral spinal fluid
72
549
1.32
1.47
1.5
1.3
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
149
1240
1.21
1.46
1.3
1.3
u/ml
2.3
0.9
0.31
13
118
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
2795
28410
0.90
1.46
5.0
4.9
mmol/l
2.8
2.8
0.32
2603
26337
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
158
1324
1.20
1.45
1.7
1.6
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
5
16
3.13
1.44
1.0
1.3
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
5
16
3.13
1.44
1.0
1.4
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
5
16
3.13
1.44
7.8
3.8
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
13
66
1.97
1.43
1.4
1.1
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
9
39
2.31
1.43
1.4
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
9
39
2.31
1.43
1.4
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
9
39
2.31
1.43
1.4
1.0
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
97
773
1.26
1.42
1.2
1.3
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
69
527
1.32
1.40
1.1
1.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
31
205
1.52
1.40
2.5
2.4
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
10
46
2.18
1.40
1.4
1.3
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
7
29
2.42
1.39
2.0
1.6
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
98
785
1.26
1.38
3.2
1.4
g/l
0.6
0.4
0.17
81
671
(43055514) Macroprolactin [Presence] in Serum or Plasma
12
60
2.00
1.38
1.3
1.5
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
5
17
2.94
1.36
2.0
3.6
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
66
504
1.32
1.35
1.5
1.5
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
18
105
1.72
1.33
1.2
1.3
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
53
706
0.75
1.32
1.5
1.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
17
98
1.74
1.31
1.6
1.4
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
17
98
1.74
1.31
1.6
1.4
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
87
693
1.26
1.30
2.7
1.4
g/l
0.0
0.0
0.34
77
634
(3013139) Helicobacter pylori Ag [Presence] in Stool
226
1973
1.16
1.30
1.3
1.2
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
9
43
2.10
1.30
1.4
1.8
g/l
11.8
11.4
—
9
32
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
81
640
1.27
1.30
2.7
1.4
g/l
0.0
0.0
0.00
72
591
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
32
462
0.69
1.30
1.7
1.7
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
82
649
1.27
1.30
2.7
1.4
g/l
0.0
0.0
0.00
72
592
(3019150) Specific gravity of Urine by Refractometry
641
5951
1.10
1.29
4.4
4.0
kg/l
1.0
1.0
0.06
121
871
(3016750) Collection duration of Urine
23
145
1.59
1.28
1.7
2.2
min
493.3
500.2
0.17
18
111
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
339
3044
1.13
1.28
3.1
2.6
ug/l
0.8
0.7
0.47
237
1935
(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay
5
18
2.78
1.28
7.8
3.5
mg/l
22.6
21.4
—
5
18
(3033799) Differential panel - Peritoneal fluid
10
48
2.09
1.27
2.5
2.2
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
11
55
2.00
1.27
2.3
2.4
mmol/l
6.6
7.6
—
6
28
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
233
2044
1.15
1.26
2.4
2.4
au/ml
17.8
23.4
0.61
18
115
(3017509) Phencyclidine [Presence] in Urine
6
25
2.40
1.24
1.2
1.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
31
212
1.47
1.22
4.2
4.0
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
112
1348
0.82
1.22
3.2
3.2
—
—
—
0
0
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
16
93
1.72
1.21
1.4
1.6
ug/l
0.3
0.4
—
10
56
(3005322) IgE [Units/volume] in Serum or Plasma
214
1875
1.15
1.19
1.3
1.3
u/ml
110.6
195.7
2.69
196
1735
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
6
26
2.31
1.18
23.2
9.6
mmol/l
5.0
6.1
—
6
26
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
146
1709
0.85
1.18
1.4
1.4
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
33
231
1.43
1.17
1.3
1.3
u/ml
2.2
0.9
0.26
17
98
(3019309) Folate [Moles/volume] in Red Blood Cells
531
4912
1.10
1.17
1.8
1.7
nmol/l
1187.4
1166.9
0.19
415
3722
(3014051) Protein [Presence] in Urine by Test strip
50
656
0.76
1.15
1.9
2.1
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
8
39
2.05
1.15
2.1
3.0
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
5
20
2.50
1.15
1.2
1.3
u/l
17.2
21.3
—
5
20
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
5
20
2.50
1.15
1.4
1.7
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
269
2403
1.13
1.13
1.2
1.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
48
631
0.76
1.13
1.4
1.5
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
7
30
2.34
1.12
4.9
10.7
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
841
7947
1.08
1.12
3.3
3.2
mg/l
956.6
299.6
1.80
512
4818
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
7
31
2.26
1.10
1.6
2.4
u/field
1.1
0.8
—
7
31
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
72
575
1.26
1.10
1.5
1.3
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
96
792
1.22
1.09
1.4
1.3
u/ml
3.6
5.4
0.51
16
130
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
10
52
1.93
1.06
1.1
1.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
12
67
1.79
1.04
4.5
1.5
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
12
67
1.79
1.04
4.5
1.5
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
12
67
1.79
1.04
4.5
1.5
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
5
22
2.27
1.03
1.8
1.2
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
94
780
1.21
1.03
1.4
1.3
u/ml
1.8
6.4
0.63
11
80
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
7
34
2.06
1.03
1.1
1.2
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
11
60
1.84
1.02
1.0
1.1
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
30
213
1.41
1.01
1.8
2.2
u/field
1.8
2.1
0.08
12
90
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
10
177
0.56
1.01
34.4
16.9
nmol/l
1107.3
1458.2
—
10
172
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
52
405
1.29
0.99
1.2
1.1
%
122.7
117.8
0.44
46
364
(3023410) Appearance of Cerebral spinal fluid
36
266
1.36
0.98
1.6
1.4
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
40
526
0.76
0.97
1.5
1.5
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
56
442
1.27
0.96
1.3
1.4
—
—
—
0
0
(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum
0
31
0.00
0.96
0.0
1.0
—
0.2
—
0
20
(3000093) Morphology [Interpretation] in Blood Narrative
28
199
1.41
0.95
1.3
1.1
—
—
—
0
0
(3000012) Reticulocyte production index
18
117
1.54
0.93
1.6
1.5
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
10
172
0.58
0.93
19.2
12.3
nmol/l
708.7
822.0
—
10
165
(3035320) C reactive protein [Mass/volume] in Body fluid
27
192
1.41
0.92
2.1
2.3
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
6
28
2.14
0.91
4.7
5.9
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
6
28
2.14
0.91
2.3
3.0
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
47
366
1.29
0.91
1.2
1.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
129
1118
1.16
0.89
4.8
4.2
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
20
135
1.48
0.89
1.3
1.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
53
421
1.26
0.89
1.2
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
53
423
1.26
0.86
1.2
1.1
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
52
415
1.26
0.85
1.1
1.1
u/ml
2.1
3.0
0.53
31
188
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
109
937
1.17
0.84
1.6
1.9
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
6
31
1.94
0.84
2.2
1.1
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
287
3130
0.91
0.83
1.6
1.7
%
1.4
1.4
0.85
248
2772
(3014599) Egg white IgE Ab [Units/volume] in Serum
10
166
0.60
0.83
1.1
1.1
u/ml
0.3
1.5
—
5
49
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
18
121
1.49
0.82
3.7
2.0
ug/l
24.9
85.8
0.47
18
110
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
8
46
1.74
0.82
1.0
1.1
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
88
745
1.19
0.82
2.8
1.4
g/l
38.4
37.9
0.36
76
622
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
17
248
0.68
0.80
1.2
1.1
—
—
—
0
0
(4268621)
38
294
1.30
0.79
2.2
2.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
40
312
1.29
0.79
1.8
1.3
—
—
—
0
0
(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum
0
25
0.00
0.79
0.0
1.0
—
0.0
—
0
13
(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid
0
25
0.00
0.79
0.0
1.2
—
30.4
—
0
7
(4146454)
21
293
0.71
0.78
2.2
2.7
—
—
—
0
0
(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum
0
27
0.00
0.77
0.0
1.0
—
0.0
—
0
14
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
32
243
1.32
0.77
1.2
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
50
616
0.81
0.77
2.7
2.8
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
16
107
1.50
0.76
13.4
7.0
mg/l
60.5
64.0
0.16
11
76
(3014148) Varicella zoster virus Ab [Titer] in Serum
42
332
1.27
0.76
1.3
1.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
35
449
0.78
0.75
1.6
1.6
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
97
1121
0.86
0.74
2.1
1.7
mg/l
3.3
3.6
0.19
69
785
(3020682) Albumin/Creatinine [Ratio] in Urine
872
8363
1.06
0.74
4.1
4.0
mg/mmol
12.1
10.1
0.28
522
5113
(3022217) INR in Platelet poor plasma by Coagulation assay
344
3196
1.09
0.74
21.6
24.8
inr
1.2
1.3
2.34
63
485
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
17
116
1.47
0.74
2.2
1.2
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
30
391
0.77
0.73
1.5
1.5
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
5
25
2.00
0.72
1.0
1.1
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
7
40
1.75
0.71
1.1
1.2
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
5
26
1.92
0.70
1.2
2.4
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
22
160
1.38
0.70
1.0
1.1
u/l
1.2
1.1
—
10
84
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
15
101
1.49
0.70
1.2
1.0
—
—
—
0
0
(3019977) pH of Arterial blood
17
118
1.44
0.69
1.5
2.7
ph
7.4
7.4
—
6
36
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
25
329
0.76
0.67
1.0
1.1
u/ml
0.2
0.3
—
5
84
(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine
5
28
1.79
0.66
1.2
3.2
—
15.5
—
0
8
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
238
2580
0.92
0.64
1.8
1.9
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
11
166
0.66
0.64
1.2
1.4
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
11
166
0.66
0.64
1.4
1.4
—
572.5
—
0
16
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
48
580
0.83
0.64
1.4
1.4
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
8
127
0.63
0.64
2.5
1.9
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
48
579
0.83
0.63
1.4
1.4
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
2604
25733
1.05
0.63
5.9
5.7
mmol/mol
39.3
39.5
0.47
2436
23913
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
48
578
0.83
0.62
1.4
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
38
306
1.24
0.62
1.8
1.3
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
8
49
1.63
0.62
1.1
1.0
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
48
577
0.83
0.61
1.4
1.4
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
5
30
1.67
0.61
1.2
2.4
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
8
50
1.60
0.61
1.1
1.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
38
307
1.24
0.61
1.8
1.3
—
—
—
0
0
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
0
20
0.00
0.60
0.0
2.5
—
3.6
—
0
20
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
93
817
1.14
0.60
1.2
1.1
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
12
80
1.50
0.59
1.1
1.1
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
100
884
1.14
0.59
1.6
1.6
iu/ml
0.4
0.2
0.27
23
180
(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum
0
23
0.00
0.58
0.0
1.0
—
1.6
—
0
12
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
106
942
1.13
0.58
2.6
1.8
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
33
264
1.25
0.58
2.1
2.0
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
6
35
1.72
0.57
1.0
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
271
2896
0.93
0.54
1.9
1.9
—
—
—
0
0
(40761535) Cells panel - Urine sediment
204
2204
0.92
0.54
3.8
3.4
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
26
204
1.28
0.54
1.2
1.1
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
9
61
1.48
0.53
1.1
1.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
15
108
1.39
0.53
1.1
1.1
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
6
39
1.54
0.53
3.2
2.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
93
826
1.13
0.53
1.2
1.2
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
10
66
1.52
0.52
1.3
3.1
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
10
66
1.52
0.52
1.3
3.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
51
433
1.18
0.52
1.1
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
89
789
1.13
0.52
1.4
1.4
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
29
359
0.81
0.52
1.1
1.1
u/ml
0.7
3.8
—
8
143
(40768446) Kidney Pathology biopsy report
14
100
1.40
0.51
1.6
1.6
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
6
40
1.50
0.51
1.0
1.1
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
11
75
1.47
0.50
10.8
6.7
mmol/l
25.0
25.2
0.08
11
70
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
13
92
1.41
0.50
1.9
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
13
92
1.41
0.50
1.9
1.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
196
1816
1.08
0.50
3.1
2.9
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
38
316
1.20
0.49
1.2
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
50
427
1.17
0.49
1.1
1.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
50
428
1.17
0.48
1.1
1.1
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
22
172
1.28
0.48
1.0
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
37
308
1.20
0.48
1.2
1.0
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
43
364
1.18
0.47
1.2
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
97
872
1.12
0.47
2.1
1.7
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
32
263
1.22
0.47
1.2
1.2
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
12
85
1.41
0.46
1.2
1.1
%
96.2
92.5
—
6
40
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
12
85
1.41
0.46
1.0
1.0
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
7
48
1.46
0.46
1.1
1.3
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
55
476
1.16
0.46
1.2
1.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
237
2525
0.93
0.46
1.7
1.7
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
18
138
1.31
0.45
1.1
1.2
u/l
199.3
310.0
0.65
18
123
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
7
50
1.40
0.45
1.0
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
180
1673
1.08
0.44
1.8
1.8
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
45
385
1.17
0.44
2.6
2.6
%
13.5
13.2
0.66
45
380
(3001964) Herpes simplex virus Ag [Presence] in Specimen
10
69
1.45
0.44
2.2
1.2
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
7
51
1.37
0.44
2.1
1.1
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
25
202
1.24
0.43
1.9
2.3
ml
624.8
633.4
0.03
18
139
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
9
129
0.70
0.43
1.1
1.5
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
90
811
1.11
0.43
1.2
1.1
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
12
87
1.38
0.42
1.2
1.1
%
89.7
91.6
—
6
41
(3039162) Centromere protein B Ab [Units/volume] in Serum
44
378
1.17
0.42
1.3
1.3
u/ml
51.9
39.1
—
5
20
(40765089) Chromosome analysis panel - Blood by G-banded
8
57
1.40
0.42
1.0
1.0
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
28
338
0.83
0.42
1.4
1.6
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
8
58
1.38
0.41
1.1
1.2
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
16
0.00
0.41
0.0
1.4
—
2.3
—
0
16
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3007542) Rye IgE Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.1
—
0.2
—
0
7
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
8
59
1.36
0.41
1.0
1.5
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
46
398
1.16
0.40
1.8
1.4
u/l
33.3
28.1
0.41
38
305
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
23
186
1.24
0.40
1.2
1.3
—
—
—
0
0
(3018001) Oat IgE Ab [Units/volume] in Serum
0
18
0.00
0.40
0.0
1.1
—
0.1
—
0
8
(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum
0
18
0.00
0.40
0.0
1.0
—
8.8
—
0
13
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
326
3416
0.95
0.39
7.8
6.1
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
38
442
0.86
0.39
1.1
1.1
iu/ml
33.7
1306.0
—
9
102
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
15
115
1.31
0.38
2.1
2.0
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
17
133
1.28
0.38
1.3
1.1
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
35
298
1.18
0.38
1.5
1.7
—
1554.3
—
0
7
(3011397) Hemoglobin [Presence] in Urine by Test strip
658
6383
1.04
0.37
4.0
3.6
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
23
188
1.22
0.37
1.2
1.3
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1818
17935
1.03
0.37
3.2
3.0
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
8
115
0.69
0.37
1.0
1.2
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
34
397
0.85
0.37
1.0
1.1
u/ml
1.9
3.0
0.58
11
153
(3004716) Salmonella sp identified in Stool by Organism specific culture
136
1462
0.93
0.36
1.4
1.4
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
48
422
1.14
0.36
1.2
1.2
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
70
631
1.11
0.35
1.3
1.2
u/ml
13.5
3.4
—
9
49
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
20
162
1.24
0.35
1.5
1.3
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
6
43
1.40
0.35
1.2
3.5
—
—
—
0
0
(4306422)
48
423
1.14
0.35
1.2
1.2
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
10
134
0.75
0.35
1.7
5.9
—
52.6
—
0
34
(3024932) HLA-DR beta [Type]
10
74
1.35
0.32
1.0
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
45
507
0.89
0.31
1.7
1.3
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
44
496
0.89
0.31
1.5
1.5
—
—
—
0
0
(4027681)
20
165
1.21
0.31
1.3
1.2
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
43
485
0.89
0.31
1.4
1.4
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
51
456
1.12
0.31
3.1
3.2
nmol/l
0.8
0.8
0.03
42
346
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
7
53
1.32
0.30
1.1
1.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
119
1111
1.07
0.30
1.7
1.6
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
7
54
1.30
0.30
1.0
1.1
u/ml
118.2
45.0
—
7
54
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
10
75
1.33
0.30
1.1
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
142
1335
1.07
0.30
1.6
1.7
—
—
—
0
0
(3034426) Prothrombin time (PT)
13
102
1.28
0.30
1.2
1.2
—
—
—
0
0
(4198724)
12
93
1.29
0.30
2.5
1.8
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
60
544
1.10
0.29
1.9
2.1
nmol/l
0.9
0.8
1.17
48
452
(3000034) Microalbumin [Mass/volume] in Urine
22
260
0.85
0.29
4.3
2.9
mg/l
43.1
21.9
0.39
17
181
(3005033) Fetal Nuchal fold Thickness US
43
482
0.89
0.29
1.4
1.4
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
15
121
1.24
0.28
2.5
2.9
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
34
298
1.14
0.28
1.9
1.4
—
—
—
0
0
(3024471) HLA-A [Type]
10
76
1.32
0.28
1.0
1.0
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
25
214
1.17
0.27
1.2
1.2
mg/l
40.3
32.7
0.26
20
179
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
16
194
0.82
0.27
1.0
1.1
iu/ml
5.4
11.4
—
5
43
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
104
971
1.07
0.27
1.8
1.9
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
34
299
1.14
0.27
1.9
1.4
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
42
376
1.12
0.26
1.1
1.3
mmol/l
7.7
7.6
0.07
31
275
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
17
203
0.84
0.25
1.0
1.0
ng/l
34.9
50.6
0.70
12
133
(3005988) Vibrio sp identified in Specimen by Organism specific culture
34
301
1.13
0.25
1.9
1.4
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
82
762
1.08
0.25
1.3
1.1
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
39
349
1.12
0.25
1.7
1.5
%
65.2
59.7
0.37
24
219
(3008401) Mugwort IgE Ab [Units/volume] in Serum
43
476
0.90
0.24
1.0
1.1
u/ml
0.7
1.1
0.28
25
209
(3029075) Extractable nuclear Ab panel - Serum
10
78
1.28
0.24
1.2
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
19
161
1.18
0.24
1.0
1.0
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
6
84
0.71
0.24
1.2
1.0
—
3.8
—
0
15
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
17
143
1.19
0.23
1.3
1.4
pmol/l
115.4
262.5
—
10
48
(1001926) Buprenorphine [Presence] in Urine by Screen method
65
702
0.92
0.23
2.3
2.0
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
72
669
1.08
0.23
1.6
1.6
e6/l
17819.8
10891.4
0.58
56
489
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
79
737
1.07
0.23
1.4
1.4
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
19
162
1.17
0.22
1.0
1.0
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
17
200
0.85
0.22
1.0
1.0
ng/l
850.6
714.0
0.40
12
129
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
7
93
0.75
0.22
1.0
1.5
ug/l
7.5
8.5
—
7
93
(3042733) HLA Ab [Presence] in Serum
10
79
1.27
0.22
4.6
4.7
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
5
42
1.19
0.21
1.0
1.1
—
—
—
0
0
(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid
0
11
0.00
0.21
0.0
5.4
—
240.3
—
0
6
(3011325) HIV 1+2 Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3020618) Glucose [Moles/volume] in Synovial fluid
0
10
0.00
0.21
0.0
1.1
—
6.1
—
0
5
(3018834) Bilirubin.total [Presence] in Urine by Test strip
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.8
—
12.6
—
0
12
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
5
43
1.16
0.21
3.8
5.2
—
—
—
0
0
(3042951) Complement C1q Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.2
—
24.4
—
0
5
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
13
0.00
0.21
0.0
6.7
—
—
—
0
0
(3007700) Barley IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
0.1
—
0
7
(3028300) Cannabinoids [Presence] in Urine
84
893
0.94
0.20
2.0
1.9
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
17
198
0.86
0.20
1.0
1.0
ng/l
277.3
361.6
0.70
12
132
(3019420) Tryptase [Mass/volume] in Serum or Plasma
17
145
1.17
0.20
3.6
1.5
ug/l
25.1
8.7
0.42
17
120
(3010937) Rubella virus Ab [Presence] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
0
14
0.00
0.20
0.0
1.0
—
171.5
—
0
14
(3048879) Bone marrow aspiration report
6
48
1.25
0.20
1.2
1.7
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
6
48
1.25
0.20
1.0
1.6
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
90
849
1.06
0.20
1.4
1.3
miu/ml
226.4
219.0
0.07
44
425
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
9
112
0.80
0.20
1.2
1.1
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
34
307
1.11
0.20
1.5
1.6
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
35
386
0.91
0.20
1.5
1.5
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
20
229
0.87
0.20
1.8
1.2
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
12
99
1.21
0.19
1.8
1.7
—
—
—
0
0
(4010399)
192
1991
0.96
0.19
1.4
1.4
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
14
118
1.19
0.19
1.3
1.9
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
77
818
0.94
0.19
1.9
2.0
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
67
627
1.07
0.19
2.9
2.3
ug/min
145.5
97.0
0.31
41
376
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
21
238
0.88
0.18
1.3
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
21
238
0.88
0.18
1.3
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
21
238
0.88
0.18
1.3
1.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
84
888
0.94
0.18
1.9
2.0
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
7
60
1.17
0.17
1.0
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
21
237
0.89
0.17
1.3
1.1
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
2741
27310
1.02
0.16
4.8
4.5
mmol/l
5.9
5.9
0.44
2553
25030
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
21
236
0.89
0.16
1.3
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
21
236
0.89
0.16
1.3
1.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
992
10038
0.98
0.16
2.8
2.8
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
10
120
0.83
0.16
9.0
11.1
—
—
—
0
0
(3024263) Appearance of Synovial fluid
12
141
0.85
0.16
1.8
1.6
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
84
884
0.95
0.16
1.9
2.0
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
13
111
1.17
0.15
1.5
2.0
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
76
0.79
0.15
1.2
1.1
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
9
78
1.15
0.15
1.1
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
49
458
1.07
0.15
2.0
1.7
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
37
400
0.92
0.15
2.5
2.6
—
—
—
0
0
(3008898) HLA-B27 [Presence]
110
1057
1.04
0.14
1.1
1.1
—
—
—
0
0
(4024509)
26
285
0.91
0.14
1.7
1.6
—
—
—
0
0
(4094501)
73
767
0.95
0.14
1.0
1.1
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
15
170
0.88
0.13
1.0
1.1
u/ml
0.3
1.3
—
8
62
(3003888) Timothy IgE Ab [Units/volume] in Serum
46
490
0.94
0.13
1.1
1.1
u/ml
3.4
4.8
0.61
28
260
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
8
100
0.80
0.13
3.1
2.6
umol/l
30.6
29.0
—
8
70
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
20
222
0.90
0.13
1.3
1.4
mmol/l
10.3
11.7
—
8
56
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
118
1140
1.04
0.12
1.3
1.4
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
21
231
0.91
0.12
1.1
1.4
nmol/l
1.4
1.4
0.05
21
209
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
85
1.18
0.12
1.2
1.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
84
875
0.96
0.12
1.9
1.9
—
—
—
0
0
(3000492) Spirometry study
266
2605
1.02
0.12
1.5
1.4
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
21
191
1.10
0.11
1.6
1.6
—
68.4
—
0
16
(3028679) Herpes simplex virus Ab [Presence] in Serum
15
134
1.12
0.11
1.2
1.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
161
1572
1.03
0.10
1.0
1.1
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
22
203
1.08
0.09
1.6
1.6
promille
0.9
1.2
0.48
16
160
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
20
184
1.09
0.09
1.1
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
28
262
1.07
0.09
1.1
1.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
525
5301
0.99
0.08
1.3
1.3
iu/ml
40.1
33.0
0.37
175
1627
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
27
254
1.06
0.07
1.8
1.4
%
35.8
33.3
0.13
15
156
(3004616) Nuclear Ab [Presence] in Serum
39
372
1.05
0.07
1.5
1.2
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
16
174
0.92
0.07
1.1
1.2
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
8
77
1.04
0.07
1.4
1.8
—
—
—
0
0
(44813793)
18
194
0.93
0.07
1.1
1.1
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
9
84
1.07
0.07
2.3
2.6
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
9
85
1.06
0.07
1.7
1.2
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
8
93
0.86
0.06
1.4
1.5
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
8
95
0.84
0.06
1.0
1.2
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
9
100
0.90
0.06
1.1
1.3
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
9
102
0.88
0.06
1.7
1.5
—
1182955.0
—
0
10
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
9
103
0.87
0.06
1.4
1.1
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
15
162
0.93
0.06
1.2
1.6
mmol/l
9.3
7.9
—
8
98
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
12
131
0.92
0.05
1.2
1.1
miu/ml
1737.4
1530.5
0.26
12
131
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
12
110
1.09
0.05
1.3
1.8
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
46
446
1.03
0.04
1.1
1.1
u/ml
0.1
2.1
—
7
114
(3019832) Treponema pallidum Ab [Presence] in Serum
230
2276
1.01
0.04
1.6
1.6
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
20
189
1.06
0.04
1.1
1.0
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
13
140
0.93
0.04
1.1
1.4
nmol/l
123.2
136.9
1.45
13
140
(3029634) Reagin Ab [Titer] in Serum by VDRL
38
368
1.03
0.04
1.6
1.9
—
4.0
—
0
7
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
320
3222
0.99
0.03
1.6
1.7
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
12
113
1.06
0.01
1.8
2.4
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
17
163
1.04
0.01
1.1
1.2
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
18
173
1.04
0.01
1.3
1.1
ratio
1.0
1.0
—
6
61
(3034274) Bile acid [Moles/volume] in Serum --fasting
33
323
1.02
0.01
1.4
2.1
umol/l
5.6
5.4
0.03
24
228
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
510
5090
1.00
0.01
1.3
1.3
u/ml
14.9
11.9
0.34
184
2007
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
55
557
0.99
0.01
1.0
1.1
u/ml
1.3
1.5
0.12
27
223
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
14
134
1.04
0.00
1.1
1.0
—
—
—
0
0
(4211845)
15
144
1.04
0.00
1.9
3.2
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
217
2164
1.00
0.00
2.1
2.3
ug/l
7.4
7.1
0.06
189
1885
(3006270) Folate [Moles/volume] in Blood
25
252
0.99
0.00
1.1
1.2
nmol/l
356.5
387.5
0.32
20
227
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
15
145
1.03
0.00
1.3
1.1
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
32
315
1.02
0.00
1.7
2.2
mg/l
38.9
23.5
—
10
76
(3025130) Human papilloma virus identified in Specimen
42
415
1.01
0.00
1.8
1.7
—
—
—
0
0
(4034850)
96
961
1.00
0.00
12.3
9.2
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
13
131
0.99
0.00
1.0
1.1
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
19
191
0.99
0.00
1.5
1.3
—
1.6
—
0
15
(3023511) Choriogonadotropin [Units/volume] in Urine
51
511
1.00
0.00
1.4
1.3
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
14
136
1.03
0.00
1.6
1.4
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
17
173
0.98
0.00
1.1
1.1
—
—
—
0
0
(3034614) HLA Ag [Interpretation]
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3027696) Helicobacter pylori Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
1228.0
—
0
5
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
8.6
—
—
—
0
0
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
62
620
1.00
0.00
3.6
4.1
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
9
97
0.93
0.00
1.0
1.1
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
59
590
1.00
0.00
2.9
3.4
mg/l
35.1
24.0
0.83
33
366
(3002619) Bacteria identified in Specimen by Culture
5
52
0.96
0.00
1.0
1.2
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
6
68
0.88
0.00
1.2
1.1
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002719) Hemoglobin [Mass/volume] in Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
13
130
1.00
0.00
2.0
3.2
—
—
—
0
0
(3045519) Venlafaxine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
690.5
—
0
7
(4015189)
6
65
0.92
0.00
4.8
2.4
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
7
69
1.01
0.00
1.1
1.6
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
7
69
1.01
0.00
1.4
1.6
—
—
—
0
0
(3013862) HLA-DP [Type]
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
7
78
0.90
0.00
1.1
1.3
umol/l
16.0
17.9
—
7
72
(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
23
230
1.00
0.00
1.3
1.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3017400) Magnesium [Moles/volume] in Urine
0
6
0.00
0.00
0.0
1.0
—
2.4
—
0
6
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
23
230
1.00
0.00
1.6
1.5
g/l
1.1
1.0
0.80
23
230
(3032057) Clostridioides difficile [Presence] in Stool
5
55
0.91
0.00
1.8
1.9
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029612) Listeria sp Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
0
8
0.00
-0.00
0.0
4.3
—
—
—
0
0
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3040893) Potassium [Moles/volume] in Capillary blood
0
8
0.00
-0.00
0.0
2.4
—
4.5
—
0
8
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
0
8
0.00
-0.00
0.0
4.3
—
—
—
0
0
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_ENDOCRINE_EXALLC – Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).